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ABSTRACT 
 
 
 
 The Claisen rearrangement of chorismate to prephenate has become an important 
model system for developing understanding of enzymatic catalysis as well as for 
computational treatment of enzyme active sites. This thesis presents general methods for 
the computational design of enzyme active sites and applies these methods to the design of 
catalysts for the chorismate-prephenate rearrangement. The computational methods 
described allow the incorporation of transition-state structures and other small molecules 
into protein design calculations. These design procedures were tested through redesign of 
the active site of Escherichia coli chorismate mutase. The six predicted mutations were 
experimentally characterized and most maintained or increased the catalytic activity of the 
enzyme. To further investigate the context of the mutations predicted in the calculation and 
the tolerance of a natural enzyme to secondary active site mutations, extensive substitution 
experiments were performed. The effect of every amino acid in five active site hydrophobic 
positions and one N-capping position was evaluated.  These experiments clarified some of 
the strengths and weaknesses of the computational modeling procedure.  Finally, attempts 
to design a completely new enzyme for catalysis of the chorismate-prephenate 
rearrangement are discussed. 
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Chapter 1 
 
 
 
Introduction 
 
 
 
 
 Enzymes are excellent catalysts, accelerating the rates of chemical reactions by as 
much as 10
19
 fold.
1
 A great deal is now known about the structures of enzymes
2
 and the 
chemical mechanisms of the reactions they catalyze.
3
 It has been appreciated for more 
than 80 years that catalysts can accelerate the rates of chemical reactions by facilitating 
the formation of their transition states.4-6  However, the questions that remain unanswered 
are likely to motivate enzymologists and protein design groups for some time: 
 
How do enzymes facilitate formation of the transition state of a reaction? 
 
How can these physical principles be employed to design new enzymes? 
 
While these two questions form central themes in this thesis, the dominant focus of the 
work presented here may be the degree to which the questions remain largely 
unanswered.  
 The primary objective of the thesis research was to use computational protein 
design methods to develop a new catalyst for the Claisen rearrangement of chorismate to 
prephenate. The rearrangement offered a compelling test case for the development and 
testing of computational enzyme design approaches. Its status as a rare “pure” enzyme-
catalyzed reaction, an intramolecular reaction that does not require general acids or bases, 
has no intermediate steps, and proceeds through the same mechanism in enzyme and in 
solution,7-9 has made it a benchmark for development of hybrid quantum mechanical 
   
  2 
methods for studying enzymes and the focus of renewed debate about the fundamental 
origins of catalysis.10 Transition state structures for the rearrangement have been well 
characterized by computational and experimental methods,7-11 and their compact 
configuration makes them especially suited for modeling in the protein design 
framework. 
 While the rational, computational design of completely new protein catalysts has 
been accomplished,12,13 the application of protein design methods to enzyme catalysis is 
still in its earliest stages of development. Computational protein design methods optimize 
the identity of amino acid side chains with respect to an energy function typically 
containing terms for van der Waals, hydrogen bonding, electrostatics, and solvation 
energies.14-17 Because these calculations represent very difficult optimization problems, 
discrete representations of side chain conformations must be used18-20 and a number of 
specialized search algorithms have been developed.21-23 The process has proven effective 
in creating thermostable proteins, ligand-binding proteins, and even new folding 
topologies.24-26 In applying these methods to the design of enzymes, however, new 
approaches must be developed to reflect the special energetics of the catalytic process.  
This last element represents the most difficult challenge of computational enzyme design.  
Because we do not yet have a complete understanding—let alone a consistent quantitative 
description—of the molecular and atomic interactions that enable enzyme catalysis,27,28 it 
might seem premature to attempt to rationally design new enzymes. However, I think that 
it is worthwhile to try and I also believe that the two questions highlighted above will be 
answered gradually and in concert as we refine and experimentally test theoretical models 
of enzymatic reactions. 
 While a computationally designed new enzyme was not realized in this thesis 
research, the following five chapters present progress toward the goal and lessons learned 
along the way. 
 Chapter 2 discusses methods for modeling small molecules during the process of 
an active site design calculation.  The placement of small molecules such as enzymatic 
transition state structures represents an important obstacle in computational protein 
design methodology.  If a small molecule placement within the binding site is not known, 
as in attempts to design new enzymes, the possible translational, rotational, and 
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conformational variations of the small molecule must be considered in combination with 
side chain conformations and identities.  Because sequence design calculations already 
represent large and difficult optimization problems, the added combinatorial complexity 
introduced with the small molecule must be dealt with creatively to make the calculation 
tractable. 
 In chapter 3, an experiment is described in which the computational design 
methods described in chapter 2 were applied to the active site of E. coli chorismate 
mutase.  The six mutations predicted in the calculation were tested experimentally.  One 
mutation slightly increased the catalytic efficiency of the enzyme. 
 Chapters 4 and 5 investigate the context of the mutations described in chapter 3.  
A series of exhaustive substitutions were performed, where the effect of every amino acid 
in each of the six positions previously mutated was investigated.  For each variant with 
chorismate mutase activity in vivo, thermostabilities and kinetic parameters were 
measured. These studies were motivated by two objectives.  First, they provide 
information about the tolerance of a natural active site to the mutation of hydrophobic 
and polar residues. Second, they allow feedback with which to assess the energy 
functions used in protein design experiments. Chapter 4 investigates the five hydrophobic 
positions that were mutated in the design experiment of chapter 3. An active site N-
capping residue is studied in chapter 5; this residue is particularly interesting because the 
mutation predicted by the computational procedure in this position lost measurable 
catalytic activity. 
 Chapter 6 presents an overview of lessons from this thesis research. The measured 
stabilities and activities of active site mutations from chapter 3 and 4 are compared to 
energies from computational design calculations. Some reflections on the goal of de novo 
design are offered. 
The appendices describe work related to the design and energetics of protein 
structure in general.  Appendix A addresses the question of how specific side chains on 
the surfaces of proteins contribute to protein stability.  Specifically, the contribution of 
surface salt bridges to protein stability has been debated, in part because fixing a side 
chain in position for such an interaction could lead to a destabilizing effect when the loss 
of conformational entropy of that side chain is considered.  Networks of ionic side chains 
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had been proposed to offer a greater stabilizing influence because each individual side 
chain might experience a greater electrostatic benefit for the same entropic cost.  
Appendix A describes how thermodynamic mutant cycles were used to look for this 
cooperative effect in one system.  In Appendix B, the X-ray diffraction structure of a 
computationally designed protein is described.  Surprisingly, despite suggestions that the 
protein adopted the correct fold in solution, the crystal structure showed a dramatically 
different fold.  Although the origin of altered folding specificity is not known, evidence is 
presented that one of the crystallization reagents, dioxane, led to increased helicity and 
altered oligomerization state in solution.   
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Chapter 2 
 
 
Combinatorial Methods for Small Molecule Placement in 
Computational Enzyme Design 
 
 
 
The text of this chapter was adapted from a manuscript coauthored with Heidi K. Privett, 
Benjamin D. Allen, and Stephen L. Mayo. 
 
Lassila, J. K., Privett, H. K., Allen, B. D., and Mayo, S. L. (2006) Combinatorial methods 
for small molecule placement in computational enzyme design.  Proceedings of the 
National Academy of Sciences USA  103, 16710-16715.  
 
 
 
Abstract 
 The incorporation of small molecule transition state structures into protein design 
calculations poses special challenges because of the need to represent the added 
translational, rotational, and conformational freedoms within an already difficult 
optimization problem.  Successful approaches to computational enzyme design have 
focused on catalytic side-chain contacts to guide placement of small molecules in active 
sites.  We describe a process for modeling small molecules in enzyme design calculations 
that extends previously described methods, allowing favorable small molecule positions 
and conformations to be explored simultaneously with sequence optimization.  Because 
all current computational enzyme design methods rely heavily on sampling of possible 
active site geometries from discrete conformational states, we tested the effects of 
discretization parameters on calculation results.  Rotational and translational step sizes as 
well as side-chain library types were varied in a series of computational tests designed to 
identify nativelike binding contacts in three natural systems.  We find that conformational 
parameters, especially the type of rotamer library used, significantly affect the ability of 
design calculations to recover native binding-site geometries.  We describe the 
construction and use of a crystallographic conformer library, and find that it more reliably 
captures active-site geometries than traditional rotamer libraries in the systems tested. 
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Introduction   
 As catalysts, enzymes offer advantageous properties including dramatic rate 
enhancements, complete control over absolute stereochemistry, and nontoxic 
biodegradation.  Yet a fundamental limiting factor in the use of enzymes for chemical 
synthesis, bioremediation, therapeutics, and other applications is the availability of 
enzymes with the required activities, specificities, and tolerances to reaction conditions.  
It is therefore a major goal of computational protein design to be able to reliably create 
completely new protein catalysts with specific properties on demand.   
 A catalyst by definition must reduce the energy barrier for formation of the 
transition state.  To design transition-state-stabilizing interactions, computational protein 
design groups have incorporated transition-state or high-energy intermediate state 
structures into design calculations.  These efforts have yielded experimentally verified 
new catalytic proteins.1,2  However, substantial challenges still prevent routine or reliable 
design of enzymes.  One major challenge is in finding energy functions that are fast 
enough for large calculations but that still provide informative approximations of 
electrostatic and desolvation effects in the protein environment.3,4   This paper focuses on 
another fundamental challenge, the need to represent the large translational, rotational, 
and conformational freedoms of a small molecule within already astronomically large 
sequence design calculations. 
 Here we define protein design as the selection of amino acid sequences such that 
the resulting protein occupies a given three-dimensional fold and has desired functional 
properties.  Earlier experiments sought to redesign full protein sequences or confer 
increased thermostability,5,6 but newer work has successfully introduced other properties 
including catalytic activity, conformational specificity, ligand affinity, and even novel 
protein folds.1,2,7-9   In these examples, side-chain placement algorithms were used to 
select from a set of discrete, probable side-chain rotamers using energy functions tuned to 
produce thermostable proteins.  These calculations represent difficult optimization 
problems10 and they can also be large—a sample calculation performed on a typical 
enzyme active site yields more than 1065 possible sequence combinations, even when 
excluding movements of the small molecule. 
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 The computational demands of sequence selection prevent ligand positioning 
using standard docking procedures, which often approximate or neglect side-chain 
flexibility.11 Approaches developed specifically for the purpose of enzyme and binding 
site design have introduced other schemes to limit the calculation size.  Looger et al. used 
stationary, inflexible ligand poses in a large number of individual protein design 
calculations and demonstrated experimentally that several of the resulting proteins had 
high ligand affinity.8  Lilien et al. reported and experimentally validated an ensemble-
based method that allows ligand translation and rotation simultaneously with side-chain 
optimization but only permits mutation of two or three amino acid positions at a time.12  
Chakrabarti et al. described a method for sequence design that neglects conformational 
and positional ligand flexibility and has not been experimentally tested.13,14    
 To design new enzyme active sites, a ligand placement method must be able to 
select side chains in many positions and must consider rotational, translational, and 
conformational freedom of the small molecule.  The new catalytic proteins of Bolon and 
Mayo1 and Dwyer et al2 were designed by treating high-energy-state structures of the 
reacting molecules as extensions of contacting amino acid side-chain rotamers.  In the 
latter case, a two-step procedure was utilized, where ligands, anchoring side chains, and 
other catalytic side chains were placed through a geometric screening procedure and 
surrounding side chains were designed in a second step.2,15  We have developed a process 
for ligand placement in computational protein design calculations that expands upon 
previous work and that allows ligand rotation, translation, and conformational freedom to 
be explored combinatorially within the sequence design calculation itself.  The 
implementation of ligand placement procedures within the context of the pairwise-
decomposable protein design framework makes it possible to use a single energy function 
that can be parameterized as needed to reproduce experimental data.    
 We tested both a simple rotational and translational process for ligand placement 
as well as the previously used targeted ligand placement approach.  A contact-based 
screening method is described that allows selection of ligand positions and confomations 
compatible with catalytic contacts.  Test calculations in three systems, E. coli chorismate 
mutase, S. cerevisiae triosephosphate isomerase, and S. avidinii streptavidin, suggest that 
the success of ligand placement procedures can be quite sensitive to conformational 
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sampling parameters including rotational and translational step sizes and the types of 
rotamer libraries used.  We evaluated the efficacy of two standard rotamer libraries and 
two crystallographic conformer libraries.  Traditional rotamers are constructed from 
canonical  angles determined by statistical analysis of the Protein Data Bank,16-18 
whereas conformers have Cartesian coordinates taken directly from high-resolution 
structures.  Conformer libraries may allow more accurate modeling because they are not 
limited to ideal geometries and their sizes can be tuned more easily and naturally.19,20  In 
our tests, a backbone-independent conformer library recovered wild-type-like active site 
geometries more successfully than the other libraries, despite smaller size.  
 
Results and Discussion 
 We have implemented and tested a process for incorporation of small molecules 
into computational protein design calculations.  The procedure is general and may be 
used to place ground-state ligands or transition-state structures.  It is also amenable to 
multistate design methods that seek to explicitly reflect the energy difference between 
reactant and transition states or between alternative ligands. 
 
General Calculation Procedure 
 Each ligand placement calculation comprised five steps.  In the first step, a large 
number of discrete variations of ligand coordinates was created. Initial sets of 
orientations were created by one of two methods, either simple rotation and translation or 
a targeted placement approach, both of which are discussed in more detail in subsequent 
sections.   In the tests described here, each set of ligand variations contained 106-109 
members, reflecting rotational and translational movement as well as internal 
conformational flexibility. 
 Next, the large number of substrate orientations was reduced to a manageable 
number (< ~20,000) using both a simple hard-sphere steric potential to check for 
backbone clashes and a set of user-defined geometric criteria for side-chain/ligand 
contacts.  In this work, geometric criteria were defined to reflect the distances, angles, 
and torsions characteristic of important catalytic contacts observed in the crystal 
structures (Figure 1).   In designing an enzyme with no naturally existing precedent, ideal 
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contact geometries would be based on chemical intuition and/or quantum mechanical 
calculations.  The geometric criteria were applied as follows.  For every ligand variation, 
each of the geometric criteria was tested for satisfaction by contacts from any possible 
amino acid side-chain conformation in all designed protein positions.  If a ligand 
variation was not able to make at least one of each type of user-specified contact, that 
ligand variation was discarded from the set.   After geometric and steric pruning, the 
ligand variations remaining were only those theoretically capable of making each of the 
user-specified contacts.  
 
 
Figure 1.  Contact geometries specified in small molecule pruning step.  Ranges of 
distances, angles, and torsions were allowed that included the crystallographic 
geometries. (A) Chorismate mutase. (B) Biotin in streptavidin. (C) Triosephosphate 
isomerase Michaelis complex, modeled using an approach similar to that of reference 2.  
Asterisks indicate pseudoatoms used in geometry definitions. 
 
 In the third step, pairwise energies for all side-chain/side-chain, side-
chain/backbone, backbone/ligand, and side-chain/ligand interactions were calculated 
using the full force field.  In our work, this normally includes a scaled van der Waals 
term,21 hydrogen-bonding and electrostatic terms,22 and a solvation potential.23,24 
 The fourth step is an optional energy biasing that favors side-chain/ligand 
contacts deemed necessary for catalysis or binding.  This energy biasing step helps to 
overcome the shortcomings of molecular mechanics energy functions as well as the 
inherent limitation of treating a multi-state design problem—differential stabilization of 
transition state relative to substrate in protein versus solution—using single-state design 
algorithms.  As methods for modeling electrostatics and solvation and for designing over 
multiple states improve, the need for this biasing step should be reduced.  Previous work 
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utilized selective application of solvation energy1 or an additional search algorithm step8 
for the same purpose.  We favor the use of adjustable bias energies that can be tailored 
for specific purposes and investigated as a design variable.   
 To implement the bias, user-specified energies were added or subtracted from 
pairwise side-chain/ligand interaction energies.  We use the energy bias under two 
regimes, one for normal design calculations and another for rapid assessment of catalytic 
residue arrangements within a protein scaffold.  In normal design calculations, a small 
energy benefit is simply applied to favor specified types of side-chain/ligand contacts.  
Alternatively, to quickly identify potential catalytic residues, exaggerated energetic 
benefits and penalties are applied together.  A very large energy benefit is given for 
desired types of pairwise interactions (100 kcal/mol was used in the test cases reported 
here).  An even larger energy penalty (10,000 kcal/mol here) is applied to all other 
pairwise side-chain/ligand interactions, except when the side chain is alanine or glycine.  
In other words, the energy penalty forces all designed side chains to alanine or glycine 
unless they participate in user-specified catalytic contacts with the ligand.  Although this 
process clearly does not yield physically relevant energetics, it offers a useful tool to 
investigate the catalytic conformational space within a binding pocket.  The tests 
performed here to study the effect of sampling parameters on calculation results took 
advantage of this second approach.  Calculations performed to demonstrate sequence 
selection utilized the normal design approach of applying a simple energy benefit to 
catalytic contacts. 
 Finally, in the fifth step, optimal sequences were identified using the FASTER25,26 
or HERO27 search methods.  In the test cases described here, the result reported is the 
lowest-energy sequence with the maximal number of specified contacts.   
   
Rotation-Translation Search  
 Simple rotation and translation can be used to fill the active site with an initial set 
of ligand variations in the first step of the process described.  Because discrete steps must 
be used to rotate and translate the ligand, we evaluated the sensitivity of the calculation 
results to rotational and translational step sizes.  A series of calculations was performed 
using an alanine-containing active-site background, as discussed in step 4 above.  We 
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first tested different rotational step sizes using the crystallographic translational starting 
position with three initial random rotations. Backbone-dependent and backbone-
independent rotamer and conformer libraries were tested.   Each side-chain library was 
tested with and without inclusion of the specific crystallographic side-chain rotamers 
from the structure under examination.   
 As seen in Table 1, the results of these calculations (in terms of both RMSD 
relative to crystallographic position and number of wild-type contacts) were strongly 
dependent on the both the rotational step size and the rotamer library used.   In the case of 
chorismate mutase, only the backbone-independent conformer library was able to find 
nativelike geometry and contacts.  Figure 2 shows results from this library with the 5° 
step size.  When the crystallographic rotamers were included in the calculation, however, 
all four libraries returned nativelike results.  It should be noted that none of the three test 
case structures were included in the set of structures used to create the conformer 
libraries.  The backbone-independent conformer library appeared the most consistently 
successful with the other two test cases as well, although it showed strong dependence on 
rotational step size in streptavidin. 
 
Figure 2.  Sample results from test calculations presented in Table 1.  Crystallographic 
side chains and ligands are shown in gray.  Results from three trials using different initial 
random rotational positions are shown in red, teal, and orange.  In cases where three 
colors are not visible, the selected rotamers from two or more calculations were identical.  
Results are shown from calculations with 5° rotation and the backbone-independent 
conformer library. (A) Chorismate mutase.  An alternate backbone position was chosen 
for a glutamate-hydroxyl contact in one trial (red side chain, lower left). (B) Biotin in 
streptavidin.  Note that the biotin pentanoic acid moiety samples different conformations 
in the calculation and the surrounding side chains were not designed. (C) 
Triosephosphate isomerase. 
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Table 1.  RMSD and number of wild-type contacts as a function of rotational step size 
and rotamer librarya,b 
 
Chorismate Mutase     
    Rotational step size   
Rotamer Libraryc 30° 20° 15° 10° 5° 
Conformer: bb-ind - - 0.61 ± 0.03 (4.0) 0.55 ± 0.05 (4.0) 0.47 ± 0.04 (4.7) 
   with xtal rotamers - - 0.61 ± 0.03 (4.0) 0.55 ± 0.05 (4.0) 0.47 ± 0.04 (4.7) 
Rotamer: bb-ind - - 3.88 ± 0.37 (0.0) 2.88 ± 1.44 (0.0) 3.01 ± 1.61 (0.0) 
   with xtal rotamers - - 1.57 ± 1.70 (2.7) 0.51 ± 0.00 (4.0) 0.52 ± 0.01 (4.0) 
Conformer: bb-dep - - 3.66 ± 0.11 (1.0) 3.59 ± 0.08 (1.0) 3.60 ± 0.09 (1.0) 
   with xtal rotamers - 1.67 ± 1.78 (3.3) 1.57 ± 1.83 (3.7) 0.60 ± 0.08 (4.3) 0.54 ± 0.06 (5.0) 
Rotamer: bb-dep - - - - - 
   with xtal rotamers - - - 0.49 ± 0.04 (4.3) 0.52 ± 0.01 (4.0) 
      
Streptavidin-Biotin      
    Rotational step size   
Rotamer Libraryc 30° 20° 15° 10° 5° 
Conformer: bb-ind - - - - 0.27 ± 0.09 (5.0) 
   with xtal rotamers - 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.26 ± 0.06 (5.0) 0.20 ± 0.13 (5.0) 
Rotamer: bb-ind - - 0.77 ± 0.42 (2.3) 0.60 ± 0.14 (3.0) 0.60 ± 0.05 (2.7) 
   with xtal rotamers 0.37 ± 0.17 (5.0) 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.26 ± 0.06 (5.0) 0.30 ± 0.17 (5.0) 
Conformer: bb-dep - - - 0.25 ± 0.12 (5.0) 0.20 ± 0.07 (5.0) 
   with xtal rotamers - 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.22 ± 0.03 (5.0) 0.29 ± 0.09 (4.0) 
Rotamer: bb-dep - - - 0.82 ± 0.28 (2.3) 0.66 ± 0.02 (3.0) 
   with xtal rotamers - 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.26 ± 0.06 (5.0) 0.16 ± 0.06 (5.0) 
      
Triosephosphate Isomerase     
    Rotational step size   
Rotamer Libraryc 30° 20° 15° 10° 5° 
Conformer: bb-ind - 1.87 ± 1.07 (0.7) 3.59 ± 2.28 (1.0) 0.28 ± 0.07 (3.0) 0.24 ± 0.05 (3.0) 
   with xtal rotamers - 1.31 ± 0.29 (1.0) 1.95 ± 2.28 (1.3) 0.27 ± 0.06 (3.0) 0.15 ± 0.02 (3.0) 
Rotamer: bb-ind 5.09 ± 0.05 (0.3) 0.60 ± 0.12 (1.7) 0.55 ± 0.25 (2.3) 0.34 ± 0.04 (2.3) 0.25 ± 0.08 (3.0) 
   with xtal rotamers 5.06 ± 0.05 (0.3) 0.60 ± 0.12 (2.0) 0.37 ± 0.04 (3.0) 0.25 ± 0.04 (3.0) 0.15 ± 0.02 (3.0) 
Conformer: bb-dep - - - - - 
   with xtal rotamers - - - - 0.15 ± 0.02 (3.0) 
Rotamer: bb-dep 3.28 ± 0.73 (1.7) 0.60 ± 0.12 (1.7) 0.37 ± 0.05 (2.3) 0.31 ± 0.04 (2.3) 0.25 ± 0.08 (3.0) 
   with xtal rotamers 3.28 ± 0.73 (2.3) 0.60 ± 0.12 (2.3) 0.37 ± 0.05 (3.0) 0.29 ± 0.03 (3.0) 0.15 ± 0.02 (3.0) 
 
a  Dashes indicate that required contacts were not satisfied in at least one of three trials. 
b  Values are non-hydrogen-atom RMSD in Ångstroms relative to crystallographic ligands or bicyclic ring 
atom RMSD relative to crystallographic ligand for biotin (i.e., the pentanoic acid moiety was not 
considered in biotin RMSDs).  Averages and standard deviations from three random initial positions are 
reported.  Numbers in parentheses are the number of contacts where the amino acid position was the same 
as in the wild-type structure, averaged over the three trials.  Maximum possible number of wild-type 
contacts:  chorismate mutase, 5; streptavidin, 5; triosephosphate isomerase, 3.   
c  bb-ind: backbone-independent, bb-dep: backbone-dependent. 
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 Next, we tested various combinations of rotational and translational step sizes 
starting from random initial ligand positions and using only the backbone-independent 
conformer library (Figure 3; Table 2).   The crystallographic rotamers from the structures 
under investigation were not included in these calculations.  The results show that, 
subject to the constraints imposed by the geometries defined in the pruning step and the 
biasing step, more than one combination of rotational and translational step size is viable 
for each test case and the sensitivity of the result to step size varies among the test cases.  
 
 
Figure 3.  Effect of rotational and translational step sizes.  Each spot represents the 
average of three trials with initial random starting positions.  Missing points indicate that 
one or more trials could not identify wild-type-like contacts or else that the calculation 
was prohibitively large; no calculations were performed using a 25° rotational step size.  
Colors indicate non-hydrogen atom RMSD as described in the tables.  (A) Chorismate 
mutase (min., 0.53 Å; max., 2.61 Å)  (B) Streptavidin-biotin (min., 0.57 Å; max., 2.05 Å) 
(C) triosephosphate isomerase (min., 0.44 Å; max., 5.64 Å). 
 
 The rotation/translation tests were performed using three initial random starting 
positions for each system.  The starting positions were created by randomly rotating and 
translating the ligand within a 1 Å3 box around the ligand centroid (or the centroid of the 
bicyclic ring system in biotin).  Using the same atom comparisons as described in the 
tables, the nine initial positions had RMSDs relative to crystallographic positions of 
between 2.1 Å and 4.5 Å, with an average of 3.2 Å.  These tests do not provide full, 
unbiased searches of the active sites.   Full active site searches could be conducted using 
this method by performing separate calculations for grid points distributed evenly 
through the active site.  Given the time required to perform these smaller calculations 
(Table 2), searching an entire active site using rotational and translational perturbations 
would be computationally expensive.   For example, examining a 3.6 x 3.6 x 3.6 Å grid 
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using the 10° and 0.3 Å step sizes would require an estimated 324 hours on a 16-
processor cluster for placement of ligands and catalytic side chains in the chorismate 
mutase active site.  Thus, for initial positioning of a ligand within an active site, rotational 
and translational placement is inefficient.  However, the ability to adjust small molecule 
position and conformation simultaneously with side-chain optimization should be 
extremely valuable for refining an initial position identified from a coarser search 
method. 
 
Table 2. RMSD and number of wild-type contacts as a function of rotational and 
translational step sizesa,b 
 
Chorismate mutase      
 Rotational step size  
Translational 
step size (Å) 30° 20° 15° 10° 5° 
Time 
(10°, 
hours)c 
0.6 1.69 ± 1.54 (2.3) 2.61 ± 1.67 (1.3) 0.77 ± 0.10 (4.3) 0.73 ± 0.02 (4.0) 0.61 ± 0.06 (4.7) 3 
0.5 0.91 ± 0.20 (3.7) 0.72 ± 0.07 (4.0) 0.83 ± 0.06 (3.3) 0.74 ± 0.05 (4.0) 0.60 ± 0.13 (4.3) 10 
0.4 2.02 ± 1.99 (2.3) 0.60 ± 0.04 (4.7) 0.59 ± 0.13 (4.0) 0.57 ± 0.12 (4.3) 0.53 ± 0.13 (4.3) 11 
0.3 1.73 ± 1.51 (2.3) 0.61 ± 0.07 (4.3) 0.62 ± 0.15 (4.3) 0.58 ± 0.07 (4.0) 0.65 ± 0.04 (4.0) 12 
0.2 1.71 ± 1.53 (2.3) 0.62 ± 0.10 (4.0) 0.60 ± 0.09 (4.0) 0.54 ± 0.07 (4.0) 0.56 ± 0.05 (4.0) 33 
       
Streptavidin-biotin      
 Rotational step size  
Translational 
step size (Å) 30° 20° 15° 10° 5° 
Time 
(10°, 
hours)c 
0.6 - 1.16 ± 0.60 (3.7) 1.67 ± 1.02 (3.7) 0.88 ± 0.44 (4.3) 0.84 ± 0.48 (4.3) 5 
0.5 2.05 ± 0.59 (1.7) 0.91 ± 0.44 (5.0) 0.84 ± 0.61 (5.0) 0.99 ± 0.91 (3.7) - 18 
0.4 1.32 ± 1.39 (3.7) 0.80 ± 0.09 (5.0) 0.67 ± 0.28 (5.0) 0.96 ± 0.72 (3.7) - 19 
0.3 0.63 ± 0.16 (5.0) 1.08 ± 0.49 (5.0) 0.57 ± 0.21 (5.0) 1.03 ± 0.48 (4.3) - 18 
0.2 0.60 ± 0.32 (5.0) 0.70 ± 0.34 (5.0) 0.80 ± 0.24 (5.0) - - - 
       
Triosephosphate isomerase      
 Rotational step size  
Translational 
step size (Å) 30° 20° 15° 10° 5° 
Time 
(10°, 
hours)c 
0.6 3.80 ± 2.14 (0.3) 5.22 ± 0.32 (0.0) 1.29 ± 0.91 (1.3) 2.39 ± 2.54 (1.7) 2.40 ± 2.58 (2.0) 0.4 
0.5 3.92 ± 1.94 (0.0) 5.64 ± 0.45 (0.3) 4.47 ± 1.45 (0.0) 1.33 ± 1.01 (1.7) - 2 
0.4 3.13 ± 1.77 (0.3) 1.96 ± 1.05 (2.0) 0.47 ± 0.24 (1.7) 0.78 ± 0.66 (3.0) - 2 
0.3 3.44 ± 1.96 (0.3) 0.59 ± 0.18 (2.0) 0.60 ± 0.29 (2.3) 0.46 ± 0.11 (3.0) - 2 
0.2 2.33 ± 1.80 (0.7) 0.68 ± 0.10 (2.3) 0.49 ± 0.12 (3.0) 0.44 ± 0.11 (3.0) - 5 
 
a  Dashes indicate that required contacts were not satisfied in at least one of three trials or that the 
calculation was too large to complete. 
b  Values are non-hydrogen atom RMSD in Ångstroms relative to crystallographic ligands or bicyclic atom 
RMSD relative to crystallographic ligand for biotin (i.e. the pentanoic acid moiety was not considered in 
biotin RMSDs).  Averages and standard deviations from three random initial positions are reported.  
Numbers in parentheses are the number of contacts where the amino acid position was the same as in the 
wild-type structure, averaged over the three trials.  Maximum possible number of wild-type contacts:  
chorismate mutase, 5; streptavidin, 5; triosephosphate isomerase, 3.  
c Wall clock time; calculations performed on a 16-processor cluster. 
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Targeted Ligand Placement 
 A second approach places the small molecule with reference to a contacting side 
chain (Figure 4).   In this approach, one or more small molecule variations are placed for 
every rotamer of the selected contacting side chain in every putative active-site position.  
This process has the advantage that ligand poses are targeted more efficiently to 
orientations that are able to make productive side-chain contacts.  Previous computational 
enzyme design work utilized similar approaches.1,2  In contrast to previous methods, 
however, our procedure does not maintain any association between the targeting rotamer 
and the small molecule—once the set of ligand conformations and orientations is 
constructed in step 1, the ligand variations are all subjected to pruning, pairwise energy 
calculations, and optimization as independent entities in the calculation.  An implication 
of this procedure is that a ligand may engage in a catalytic contact with a rotamer, amino 
acid, or protein position that differs from those of the side-chain rotamer that was 
originally used to place that ligand. 
 
 
Figure 4.  Targeted placement procedure.  For a given side chain rotamer, small 
molecule ligands are placed such that they are able to meet specified geometric criteria.  
This is repeated for every possible conformation of the amino acid at every designed 
position.  Shown is a subset of orientations of a chorismate mutase transition-state 
structure in contact with one conformation of arginine.   
 
 We tested the effect of four types of side-chain libraries on the ability of a 
targeted placement process to find wild-type-like ligand positions and contacts.  For the 
three test cases, the following side-chain contacts were used to anchor the ligand:  
chorismate mutase, C11 carboxylate to arginine; streptavidin, N1 to aspartate; 
triosephosphate isomerase, O2 and O3 to histidine.   For each contact type, variations 
were allowed in the geometry of the contact, including the contacting atoms (NH1-NH2 
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vs. NE-NH1 for arginine) and variations in defined distances, angles, and dihedrals of the 
contact.   
  As with the rotational and translational search, success in achieving native active-
site conformations was highly dependent on the side-chain library used (Table 3).  Only 
the backbone-independent conformer library yielded results for all three test cases that 
were comparable to those with crystallographic rotamers included.   Using that library, all 
three systems returned all wild-type contacts with low ligand RMSD relative to the 
crystallographic position.  As with the rotation/translation search, the chorismate mutase 
case showed the strongest sensitivity to rotamer library.   Inspection of the structures 
revealed that an arginine side chain (Arg 28) occupies a conformation in the inhibitor-
bound, active enzyme structure that was not well approximated in the other rotamer 
libraries.   
 The targeted placement approach allowed a thorough and directed search of 
active-site conformational space, including between 106 and 109 small molecule 
orientations and conformations spread throughout the active site.  In contrast to the 
rotation/translation method, a full active-site search took between one and eighteen hours 
to complete using the backbone-independent conformer library and no initial starting 
position was required.   This method offers an efficient first step for defining active-site 
geometry in a new protein scaffold.   One shortcoming is that it may be difficult to 
sample the many geometrical variations of a flexible hydrogen-bonding interaction.  For 
example, the 972 variations in guanidino-carboxylate contact geometry sampled in the 
chorismate mutase case are probably adequate to reflect flexibility in this relatively rigid 
dual hydrogen-bonding interaction.  A less restrained interaction, however, such as a 
serine hydrogen bonding with a sterically unrestricted ligand carbonyl oxygen, results in 
a compromise between maintaining a manageable calculation size and modeling contact 
flexibility.  One solution is to use a targeted method to find an initial ligand position 
within the binding site and then, in a second calculation, optimize both active-site 
packing and fine rotational and translational placement of the ligand.  
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Table 3.  Results from targeted placement procedure as a function of rotamer library. 
 
Chorismate mutase    
Rotamer librarya 
log(initial ligand 
variations) 
RMSD (Å)b 
(WT contacts) 
Time 
(hours)c 
Conformer: bb-ind 7.88 0.60 (5) 16 
   with xtal rotamers 7.88 0.68 (3) 18 
Rotamer: bb-ind 8.18 3.61 (0) 51 
   with xtal rotamers 8.18 0.66 (4) 62 
Conformer: bb-dep 7.64 3.62 (1) 8 
   with xtal rotamers 7.64 0.68 (4) 9 
Rotamer: bb-dep 7.76 2.31 (1) 14 
   with xtal rotamers 7.76 0.66 (4) 16 
    
Streptavidin-biotin    
Rotamer librarya 
log(initial ligand 
variations) 
RMSD (Å)b 
(WT contacts) 
Time 
(hours)c 
Conformer: bb-ind 7.07 0.64 (5) 1.4 
   with xtal rotamers 7.07 0.64 (5) 1.4 
Rotamer: bb-ind 7.20 0.54 (4) 3.5 
   with xtal rotamers 7.20 0.34 (4) 3.4 
Conformer: bb-dep 6.35 0.37 (5) 0.2 
   with xtal rotamers 6.35 0.54 (4) 0.2 
Rotamer: bb-dep 7.17 3.50 (0) 2.6 
   with xtal rotamers 7.17 0.19 (5) 2.8 
    
Triosephosphate isomerase   
Rotamer librarya 
log(initial ligand 
variations) 
RMSD (Å)b 
(WT contacts) 
Time 
(hours)c 
Conformer: bb-ind 7.31 0.49 (3) 1.3 
   with xtal rotamers 7.31 0.49 (3) 1.3 
Rotamer: bb-ind 7.78 0.46 (3) 8.7d 
   with xtal rotamers 7.78 0.46 (3) 8.7d 
Conformer: bb-dep 6.82 7.51 (0) 0.3 
   with xtal rotamers 6.82 0.78 (3) 0.3 
Rotamer: bb-dep 7.58 0.51 (3) 4.3d 
   with xtal rotamers 7.58 0.51 (3) 4.9d 
a  bb-ind, backbone-independent; bb-dep, backbone-dependent. 
b  RMSDs calculated as described in Table 1.  Maximum possible number of wild-type contacts:  
chorismate mutase, 5; streptavidin, 5; triosephosphate isomerase, 3.  
c  Wall clock time; calculations performed on a 16-processor cluster. 
d  Calculation was performed as a series of smaller calculations. 
 
Sequence Design 
 The computational tests described in the previous sections were designed to 
evaluate the effects of calculation parameters on recovery of native enzyme geometries, 
and the design of active-site residues was limited to catalytic side chains.  However, the 
general procedure described here is equally amenable to full active-site design 
calculations.   
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 In previously published work, 18 active site residues of E. coli chorismate mutase 
were redesigned simultaneously with rotational and translational relaxation of the 
transition-state structure from the starting crystallographic position.28  The six predicted 
mutations were experimentally investigated and some were found to confer increased 
catalytic efficiency28 or thermostability (see chapter 4). A detrimental mutation predicted 
in the study underscored the importance of continued work on energy functions.  In the 
calculation that motivated this experimental work, the initial starting position of the small 
molecule was taken from the crystal structure and a limited degree of rotational and 
translational optimization was employed.   
 We performed a test calculation to demonstrate that small molecules can be 
placed simultaneously with full active-site side-chain optimization, without reference to 
any known starting position.  In a sample calculation using E. coli chorismate mutase, the 
targeted placement method was used to identify 107 small molecule variations.  In this 
example, after the geometric pruning step and elimination of variants with backbone 
steric clashes, 155 small molecule variations remained.  These variants were evaluated 
combinatorially with ten different side chain identities in twelve active-site positions.   
Using FASTER for optimization, the calculation took approximately 9 hours to complete 
on a 16-processor cluster with about 70% of the total calculation time consumed in 
calculating a surface-area-based solvation term.    
 
Conclusions 
 The described procedures allow the incorporation of small molecule placement 
directly into sequence design calculations.  The test calculations performed suggest that 
the results of computational enzyme design processes can be quite sensitive to calculation 
parameters including the rotamer library used and the coarseness of ligand positioning.  
These results emphasize that the conformational space of a calculation must be explored 
before meaningful conclusions can be reached about energy functions.      
 Given that we still have much to learn about the complex relationship between 
protein structure and catalytic activity,29,30 luck and choice of system may continue to 
play a role in the success of de novo computational enzyme design efforts for some time.  
However, the power of computational enzyme design to stringently evaluate our 
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understanding of the energetics of catalysis should not be overlooked.  Experimental 
feedback gained from both successful and unsuccessful designs will make it possible to 
critically examine energy functions for modeling active sites.  Employing quality 
transition-state structures derived from ab initio calculations and experimental evidence 
will help computational design experiments to provide more meaningful information 
about the effectiveness of energy functions.  The use of large side-chain structural 
libraries and fine movements of transition-state structures will help to reduce errors from 
conformational sampling.  Backbone relaxation and multi-state design will offer other 
important tools to improve the value of design calculations.  Finally, the construction of 
gene libraries or large numbers of computationally designed variants has great potential 
for overcoming the shortcomings of enzyme design models,31 but results from these 
experiments will be most useful for furthering our understanding of catalysis and design 
if both active and inactive variants are reported.  By critically evaluating current methods 
for computational enzyme design, we will move closer to a deeper and more practically 
useful understanding of the sequence determinants of enzyme activity in the future. 
 
 
Methods 
Structures and charges 
 PDB files were used without minimization (E. coli chorismate mutase,32 1ecm; S. 
avidinii streptavidin,33 1mk5; S. cerevisiae triosephosphate isomerase,34 1ney.  Hydrogens 
were added with REDUCE.35 
 A library of ligand internal conformations was created for each system as follows.  
Chorismate mutase:  An HF/6-31G* ab initio transition-state structure36 was used with 
only one variation—the O4 hydroxyl proton was allowed to occupy three positions, 60°, 
180°, and -35°, defined by the H-C-O-H dihedral angle.  The minima in a torsional 
profile at the HF/6-31G* level were at approximately 180° and -35°, and 60° was 
included as an option because hydrogen-bonding patterns in chorismate mutases from 
other species suggested population of that region of torsional space.  Streptavidin:  Four 
rotatable bonds in biotin were allowed to occupy three positions each (60°, -60°, 180° for 
sp3-sp3 bonds and 30°, 90°, 150° for the symmetric carboxylate group).  Thirty-four 
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conformations were excluded because of high internal energy calculated using the van 
der Waals component of the DREIDING force field.37  Triosephosphate isomerase:  The 
pdb structure used was the Michaelis complex with the substrate dihydroxyacetone 
phosphate.  In ground-state dihydroxyacetone phosphate, two rotatable bonds (defined by 
the P-O-C-C and C-C-O-H dihedral angle) were allowed to occupy three positions each 
(60°, -60°, 180°).  Three conformations were excluded because of high internal 
DREIDING van der Waals energy.  
 Ligand atomic charges were obtained by fitting charges to electrostatic potential 
from HF/6-31G* single-point energy calculations using the transition-state structure 
(chorismate mutase) or crystallographic ground-state structure (biotin, dihydroxyacetone 
phosphate).   Ab initio calculations and charge determinations were performed using 
Spartan (Wavefunction, Inc.) or Jaguar (Schrödinger, Inc.). 
 
 
Side-chain rotamer libraries 
 Standard backbone-dependent and backbone-independent rotamer libraries were 
used with expansion by one standard deviation about 1 and 2.17 
 Crystallographic conformer libraries were prepared using coordinates from 
149,813 side chains selected from 1,011 unique structures.  A clustering algorithm was 
developed based on ideas described by Shetty et al20 and is described briefly here. Every 
side-chain conformation from the raw data set is assigned to exactly one cluster.  Each 
cluster is represented by the centroid, which is the member with coordinates closest to the 
average coordinates of all cluster members.  A conformer library consists of a list of all 
of the cluster representatives and their coordinates. In our clustering algorithm, clusters 
are assigned through discrete clustering moves:  Switch allows a single raw conformer to 
leave one cluster and join another; Merge combines two clusters into one; Split allows a 
raw conformer to start a new cluster on its own.  These moves are depicted in Figure 5.   
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Figure 5.  The three clustering moves are illustrated by showing the state of a sample 
system before and after the move is performed. Each dot represents a single side-chain 
conformation taken from the PDB. Distances represent side-chain RMSDs between pairs 
of conformers. Dots sequestered together by a dashed line and colored the same are 
members of the same cluster. Darker-colored dots denote cluster representatives.   
 
 RMSDs between pairs of conformers are compared to determine whether or not to 
apply a particular move. Switch is applied so that each raw conformer is a member of the 
cluster whose centroid is closest to it.  Merge and Split are applied based on the value of 
the clustering parameter p: two clusters are merged if their centroids are within p of each 
other, whereas a conformer splits off and starts a new cluster if the closest centroid of any 
existing cluster is farther than p from it. The clustering moves are applied as follows until 
the number of clusters converges: 
 
1. Start with a small number of clusters (1 was used in this work), and randomly 
assign a single raw conformer to each as the sole member and cluster 
representative.  
2. Assign each raw conformer in the data set to the cluster whose centroid is closest. 
3. While the number of clusters is not converged: 
a. Iteratively attempt to Merge pairs of clusters until no cluster can be further 
merged.   
b. For each conformer C: 
i. Measure the distance d between C and the centroid of every 
existing cluster. 
ii. If the distance d to the closest cluster centroid is greater than p, 
Split C off as its own cluster. 
iii. Else, Switch C to the closest cluster. 
iv. Recompute the centroid for every cluster that has changed 
membership. 
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 The algorithm allows the construction of both backbone-dependent and backbone-
independent libraries to custom sizes by using clustering factor p to define the desired 
degree of similarity between independent conformers.  In this work, clustering factors of 
0.3 Å and 1.0 Å were used for backbone-dependent and backbone-independent rotamer 
libraries, respectively.   
 For all calculation types, conformer libraries were smaller than the standard 
rotamer libraries.  As an example, the number of side-chain conformations for the 
chorismate mutase calculations described in Table 3 were as follows:  backbone-
independent rotamer, 14229; backbone-independent conformer, 5955; backbone-
dependent rotamer, 7945; and backbone-dependent conformer, 5539.  
 
Calculation Parameters 
 All non-Gly, non-Pro residues reasonably within the natural active sites were 
included in calculations.  Residues with any atom within a 5 Å radius from any atom in 
the crystallographic ligands were included, less those residues separated from the natural 
ligand by backbone elements and plus a few adjacent residues not within the 5 Å cutoff.  
The positions designed were (all in chain A unless otherwise designated): chorismate 
mutase, 28, 32, 35, 39, 46, 47, 48, 51, 52, 55, 81, 84, 85, 88, 7B, 11B, 14B, 18B; 
streptavidin, 23, 24, 25, 27, 43, 45, 46, 47, 49, 50, 79, 86, 88, 90, 92, 108, 110, 112, 128, 
130; and triosephosphate isomerase, 10, 12, 95, 97, 165, 170, 211, 230. 
 In ligand placement test cases, designed residues were restricted to ligand-
contacting residues or alanine as follows: Arg, Lys, Gln, Glu, or Ala in chorismate 
mutase; Ser, Asn, Tyr, Asp, or Ala in streptavidin, and Glu, His, Lys, or Ala in 
triosephosphate isomerase.  Four calculations on triosephosphate isomerase were run as 
smaller component calculations, as indicated in Table 2, because of prohibitive size as a 
single calculation.    
 
Energy Functions and optimization 
 Energy functions included scaled van der Waals,21 hydrogen-bonding, and 
electrostatic terms.22 A surface-area based solvation potential23 was used in sequence 
design calculations but not for ligand placement, where solvation energy would have 
 
  25 
 
been heavily outweighed by geometric considerations.  Sequences were optimized with 
respect to the energy function using FASTER25,26 or HERO.27  On occasion, a top-ranked 
sequence contained more than one instance of a given specified geometric contact, owing 
to the energy benefit applied for these contacts.  In these cases, Monte Carlo38,39 was used 
to sample around the global minimum energy sequence and the top-ranked sequence with 
a single instance of each geometric contact was reported.   
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Chapter 3 
 
 
 
Computationally Designed Variants of Escherichia Coli 
Chorismate Mutase Show Altered Catalytic Activity 
 
 
 
 
The text of this chapter has been adapted from a manuscript coauthored with Jennifer R. 
Keeffe, Peter Oelschlaeger, and Stephen L. Mayo.  
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Abstract 
 Computational protein design methods were used to predict five variants of 
monofunctional E. coli chorismate mutase expected to maintain catalytic activity. The 
variants were tested experimentally and three active site mutations exhibited catalytic 
activity similar to or greater than the wild-type enzyme.  One mutation, Ala32Ser, 
showed increased catalytic efficiency. 
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Introduction 
 
 The Claisen rearrangement of chorismate to prephenate (Figure 1) is a rare 
enzyme-catalyzed pericyclic reaction that proceeds through the same mechanism 
uncatalyzed in solution. Chorismate mutases from various organisms provide rate 
enhancements of around 106 despite strong dissimilarities in three-dimensional fold.1-3 
The metabolic importance of chorismate as the key branch point in the shikimate 
pathway has prompted extensive experimental investigation of the chorismate-prephenate 
rearrangement since the 1960s4 and has driven complementation experiments to probe the 
structural determinants of enzyme catalysis.5 The concerted, unimolecular nature of the 
rearrangement and the lack of covalent protein contacts have encouraged numerous 
theoretical studies of the catalyzed and uncatalyzed reactions.  The question of how 
chorismate mutases achieve rate enhancement has been actively discussed in recent 
years.6-10 
 
 
Figure 1. Claisen rearrangement of chorismate (1) to prephenate (2). 
 
 We used computational protein design techniques to identify mutations within the 
active site of the chorismate mutase domain (EcCM) of Escherichia coli chorismate 
mutase-prephenate dehydratase (“P-protein”)11 consistent with catalytic activity. The 
objective of the study was to evaluate the viability of a rotamer-based approach with an 
empirical mechanics force field in modeling the active site. We report three active site 
mutations that permit catalytic activity at or above the level of the wild-type enzyme.  
One of these appears to have enhanced catalytic efficiency relative to wild type.  
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Materials and Methods 
Computational design 
 An ab initio calculated transition state structure12 was modeled at the position of a 
transition state analog in the EcCM crystal structure, pdb code 1ecm.3 Translation (± 0.2 
Å each axis) and rotation (± 5° each axis) of the transition state structure was allowed and 
all amino acids except glycine, proline, cysteine, and methionine were permitted in the 
following positions: 28, 32, 35, 39, 46, 47, 48, 51, 52, 55, 81, 84, 85, 88 (chain A); 7, 11, 
14, 18 (chain B).  Residues from both chains compose each of the two active sites in this 
symmetric homodimer. A backbone-dependent side chain rotamer library13 was used with 
expansion by one standard deviation about 1 and 2 for all amino acids except arginine 
and lysine.  The energy function used in the ORBIT protein design software14 was based 
on the DREIDING force field15 and includes a scaled van der Waals term,16 hydrogen 
bonding and electrostatic terms,17 and a surface-area based solvation potential.18 
Transition state partial atomic charges were obtained as previously reported.12 An 
additional energy penalty was applied to effectively eliminate from consideration all 
sequences that could not maintain key contacts between the transition state structure and 
Arg 11 and Arg 28. These contacts were previously demonstrated to be necessary for 
catalysis.19 The HERO rotamer optimization method was used to obtain the minimum 
energy amino acid sequence and conformations.20 Six mutations were predicted in the 
optimized structure: Leu7Ile, Ala32Ser, Val35Ile, Asp48Ile, Ile81Leu, and Val85Ile.  
Visual inspection and subsequent calculations indicated that four of the mutations were 
independent, so they were treated separately. 
 
Protein expression and kinetic characterization 
 The gene encoding EcCM residues 1-109 of the bifunctional chorismate mutase-
prephenate dehydratase (P protein) was amplified from genomic DNA (ATCC 700926D) 
and inserted into the pTYB11 vector from the IMPACT-CN intein fusion system (New 
England Biolabs) between the SapI and XhoI sites.  Inverse PCR mutagenesis21 was used 
to construct five variants: Leu7Ile, Ala32Ser, Val35Ile, Asp48Ile, and Ile81Leu/Val85Ile. 
Constructs were verified by DNA sequencing. Variant and wild-type proteins were 
expressed in E. coli BL21 (DE3). Expression was induced with 1 mM IPTG at OD600 = 
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0.6 and cells were grown for 18 hours at 22 °C. Cells were harvested and lysed by French 
press in 20 mM Tris-Cl pH 8.0, 500 mM NaCl, 1 mM EDTA, 10 mM MgCl2, 1 mM 
PMSF, with DNase and RNase. Chitin affinity purification was conducted with a column 
buffer containing 20 mM Tris-Cl, pH 8.0, 500 mM NaCl, and 1 mM EDTA.  On-column 
cleavage proceeded in 50 mM DTT at 25 °C for 18 hours. Mass spectrometry and SDS-
PAGE verified that this protocol results in successful cleavage and yields the expected 
product. Wild-type and variant proteins were further purified by gel filtration on a HiPrep 
Sephacryl S-100 high resolution column (Amersham Biosciences) with 20 mM Tris-Cl 
pH 7.8, 100 mM NaCl as the running buffer and final storage buffer. Protein 
characterization followed procedures recently reported for the same construct.22 Protein 
concentration was determined by Bradford assay using BSA as a standard. Chorismate 
mutase activity was determined by following the disappearance of chorismate with UV 
absorbance at 275 nm. Activity assays were conducted at 37 °C and contained 20 nM 
protein in 50 mM Tris pH 7.8, 2.5 mM EDTA, 20 mM -mercaptoethanol, and 0.01 % 
BSA.  Initial velocities were buffer-corrected and were determined with less than 6% 
depletion of initial substrate concentration. All proteins were initially tested using a 
substrate concentration range of about 50-500 μM. The wild-type and the Ala32Ser 
mutant were further assayed with substrate ranges of approximately 20-2000 μM and a 
minimum of five trials including two separate protein preparations each.  Kinetic 
parameters were determined by nonlinear fitting to the Michaelis-Menten equation.  
 
Molecular dynamics simulations 
 Molecular dynamics simulations of EcCM and mutant Asp48Ile as free enzymes 
and in complex with the oxabicyclic transition state analog23 were carried out using the 
Sander Program of the AMBER 7.0 software package.24 For symmetry, both chains were 
truncated to residues 6 through 95. The transition state analog was minimized and the 
electrostatic potential surface was calculated using DFT with B3LYP and the lacvp** 
basis set in the Jaguar 5.5 package (Schrödinger LLC). Atomic charges were obtained 
with RESP. Parameters for the transition state analog were defined according to similar 
structures in the AMBER libraries. The binding sites of the free enzymes were filled with 
water by solvating the molecules with a TIP3P25 water shell using a closeness parameter 
 
  33 
of 0.4 in xLEaP. All systems were then solvated by a truncated octahedron of TIP3P 
water 8 Å around the protein and neutralized with counter ions. The ff02EP version of the 
ff99 force field26,27 was used to represent the protein and the ligand. After minimization, 
all systems were heated to 300 K with constant volume, starting at 10 K with three 
different initial velocities. Molecular dynamics simulations were prolonged at 300 K and 
constant pressure until the backbone RMSD reached a constant value of about 1.5 Å 
compared to the first frame; this was observed after 500 to 800 ps. Average structures 
over 10 ps of the equilibrated systems were generated and analyzed visually. 
 
Results and Discussion 
 As seen in Table 1, three of the five variants showed similar or greater catalytic 
efficiency relative to the wild-type enzyme.  The Ala32Ser mutation results in a slightly 
more efficient catalyst than wild type due to both a decrease in KM and an increase in kcat.  
The fact that substrate binding is enhanced in addition to catalysis is consistent with the 
suggestion that factors stabilizing the transition state may be likely to contribute to 
ground state stabilization in the catalyzed rearrangement.28 The rate enhancement 
corresponds to a change in activation energy of less than 1 kcal/mol, making a detailed 
structural explanation unwarranted. However, it should be noted that in the predicted 
structure of this mutant, Ser 32 is capable of hydrogen bonding with Gln 88 (Figure 2), a 
residue that makes an essential contact to the ether oxygen of the breaking bond.19  
 
Table 1.  Kinetic parameters of wild-type and mutant EcCMa 
 
  kcat KM kcat/KM
 %WT 
  min-1 μM min-1μM-1 kcat/KM  
WT 2332 ± 306 304 ± 52 7.8 ± 1.0 100 
Ala32Ser 2708 ± 364 220 ± 29 12.4 ± 1.0 159 
Val35Ileb 3046 ± 172 365 ± 59 8.5 ± 1.1 109 
Leu7Ileb 2193 ± 291 249 ± 54 9.1 ± 2.4 117 
Ile81Leu/Val85Ileb 2004 ± 241 669 ± 165 3.1 ± 0.6 40 
Asp48Ilec - - - - 
a Reported errors are standard deviations from at least three trials. 
b Three mutants were assayed with a limited substrate concentration range, see text. 
c Reaction rates with the Asp48Ile mutant were within error of the uncatalyzed solution reaction. 
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Figure 2.  Predicted hydrogen bonding in the Ala32Ser chorismate mutase variant.  
Interactions in the wild type crystal structure are the same except for position 32A.  
 
 Val35Ile shows increased kcat but also increased KM, resulting in kcat/KM similar to 
wild type. The Leu7Ile mutation also does not have a significant effect on catalytic 
efficiency.  Both mutations create slightly different hydrophobic packing environments 
near the essential residue Arg 11 in the predicted structures. The double mutant, 
Ile81Leu/Val85Ile, was predicted to alter packing against the hydrophobic ring face of 
the reacting molecule. This rearrangement of hydrophobic amino acids does not result in 
substantial change in kcat. However, the mutations result in increased KM and reduced 
catalytic efficiency. The relative insensitivity of the enzyme to changes in some amino 
acids is not surprising given the recent finding that the reaction is efficiently catalyzed by 
a protein exhibiting all the characteristics of a molten globule.29 
 The Asp48Ile mutation abolished measurable catalysis under the conditions 
tested. This position makes backbone contacts to the hydroxyl group of the transition 
state analog in the EcCM crystal structure. Hydroxyl contacts to a negatively charged 
residue were suggested to create a favorable electrostatic gradient in the Bacillus subtilis 
enzyme.30 However, in the E. coli structure the Asp 48 side chain points away from the 
active site and is distant from the transition state analog.  Molecular dynamics 
simulations provide some insight into a possible function of Asp 48 that this mutant 
lacks.  Averaged structures from equilibrated systems show Asp 48 hydrogen bonding to 
Arg 11 in both the unliganded and inhibitor-bound enzyme. In simulations of unliganded 
Asp48Ile mutants, however, Arg 11 is dramatically displaced into solution, suggesting 
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that one role of Asp 48 may be to stabilize this key active site side chain in a 
conformation compatible with substrate binding and catalysis. 
 While the choice of mutations in this experiment was based solely on 
computational modeling and no sequence alignment information was used in the process, 
a BLAST search31 using the EcCM sequence as the query showed that sequence 
variations corresponding to the Ala32Ser, Val35Ile, Val85Ile, and Ile81Leu mutations 
were observed in chorismate mutases from related organisms. 
 Our design procedure stabilizes a static active site configuration with a bound 
transition state structure. Although the substrate of the reaction is not explicitly 
considered, we expect that modeling interactions using the structure and charges of the 
transition state should promote some degree of differential stabilization of the transition 
state relative to substrate. The present study demonstrates that this approach can be used 
effectively to represent the active site of a natural enzyme. In this case, the predicted 
mutations were in residues not directly contacting the reacting molecule. The favorable 
result from the Ala32Ser mutation suggests that such secondary contacts are important in 
the enzyme design process. The complete loss of catalytic activity from the Asp48Ile 
mutation implies that improved treatment of electrostatics and consideration of the 
unbound enzyme could offer some benefit in future design efforts.    
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Residues in Escherichia Coli Chorismate Mutase 
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Abstract 
 Hydrophobic side chains in enzyme active sites may contribute to catalysis 
through critical interactions that organize the active site and position the reacting 
molecule. To evaluate the sequence-space landscape for stability and catalysis in 
hydrophobic active site positions of a natural enzyme, we used site-saturation 
mutagenesis to place all 20 amino acids in five residues of the E. coli monofunctional P-
protein chorismate mutase. The ability of each mutant to promote viability in a 
chorismate mutase deletion strain was assessed, and active variants were purified and 
evaluated with respect to in vitro enzyme activity, far-UV circular dichroism, and thermal 
denaturation profiles.  We found that substitutions in many cases led to decreased activity 
and increased stability, in accord with previous descriptions of stability-activity trade-offs 
in active site residues. A few mutations led to increased catalytic efficiency relative to 
wild type. Altogether, the enzyme tolerated about 34% of the possible single mutations, 
demonstrating that the selection of hydrophobic residues is important in the design of 
functional catalysts, yet there can be considerable tolerance to substitution in some active 
site positions. 
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Introduction 
 The Claisen rearrangement of chorismate to prephenate (Scheme 1) is catalyzed 
by chorismate mutases.  This reaction is a key step in the biosynthesis of aromatic 
compounds including tyrosine and phenylalanine in plants, bacteria, and fungi. Isotope 
studies have established that both solution and enzyme-catalyzed rearrangements proceed 
through a chairlike transition state1,2 in a concerted, asynchronous [3,3]-sigmatropic 
process.3-5  
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 As a first-order intramolecular rearrangement, catalyzed without intermediate 
steps, covalent catalysis, or modification of the reaction pathway, the reaction has 
become an important model system for computational studies of enzymatic catalysis 
(recently reviewed in ref. 6).  These same features make the reaction a compelling target 
for testing computational enzyme design procedures. Because the active site 
environments of enzymes are likely to present substantial challenges to protein design 
energy functions that are normally parameterized for global stability,7,8 we were 
interested in defining the effects on stability and catalysis of a large number of mutations 
in secondary active site positions. Active site residues that do not directly hydrogen bond 
with the reacting molecule can provide information relevant to energy functions because 
they are subject to the electrostatic and desolvation factors of the active site, yet their 
mutation does not always lead to immediate loss of activity. 
 We constructed a series of mutations in the active site of a monofunctional 
Escherichia coli chorismate mutase. The E. coli enzymes fall within the AroQ class of 
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chorismate mutases,9-12 which are all-helical proteins. The Bacillus subtilis enzyme 
(BsCM) and other AroH mutases, however, adopt a homotrimeric pseudo-/-barrel 
fold.13 In E. coli, chorismate mutases are fused to their downstream biosynthetic partners, 
forming bifunctional chorismate mutase-prephenate dehydratase (P-protein) and 
chorismate mutase-prephenate dehydrogenase (T-protein) enzymes.14 Mechanistic 
investigations in the bifunctional T-protein enzyme were complicated by a rate-limiting 
step other than the Claisen rearrangement.3 However, truncated, monofunctional 
constructs of the P-protein (Figure 1A, referred to as EcCM herein) have made structural 
and mechanistic studies possible.15  The rearrangement catalyzed by EcCM shows 
expected patterns of kinetic isotope effects and no sensitivity to viscogens, strongly 
suggesting that the Claisen rearrangment is the rate-determining step.5,16  In contrast, 
BsCM appears to be limited partially by a diffusive process and partially by the chemical 
step.4,16 
 
 
 
 
Figure 1. Truncated, monofunctional chorismate mutase construct from Escherichia coli 
chorismate mutase-prephenate dehydratase, from pdb code 1ecm.  (A) Overall fold, 
showing the two chains of the symmetric homodimer in teal and gold. The 
crystallographic transition state analog is shown in spheres. (B) Active site residues 
investigated in this study. The crystallographic transition state analog is shown as well. 
 
 Previous mutagenesis and selection studies of both EcCM and BsCM enzymes 
have demonstrated the importance of positively charged active site residues poised to 
interact with the carboxylates and ether oxygen as well as negatively charged side chains 
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able to contact the hydroxyl group.17-22 The present work focuses on five hydrophobic 
active site positions in EcCM that were previously selected for mutation in a 
computational design experiment (see chapter 3): Leu7, Ala32, Val35, Ile81, and Val85 
(Figure 1B). These side chains do not hydrogen bond with the reacting molecule, but 
nonetheless may participate in catalysis by positioning the substrate, organizing charged 
and polar active site residues,23 or defining the electrostatic environment of the active 
site24. The secondary active site residues investigated in this work may also have special 
consequences for enzyme stability.  Prior mutagenesis studies have found inverse 
relationships between changes in protein stability and changes in activity following the 
mutation of active site residues, consistent with a notion that creation of a cavity with 
specialized electrostatic properties opposes the normal driving forces of protein 
stability.25-29 
 Here, we have evaluated the effects of all 19 possible single mutations in the five 
hydrophobic active site positions. Each of the 95 variants was tested for complementation 
of the auxotrophic E. coli KA12 pKIMP-UAUC system of Kast, Hilvert, and co-
workers.20,30  Biologically active variants were purified and their in vitro thermal 
stabilities and steady-state kinetic parameters were assessed. 
 
Materials and Methods 
 Materials and Strains.  E. coli KA1230 and plasmid pKIMP-UAUC20 were a gift 
from Donald Hilvert and Peter Kast.  Chorismic acid (97.5%) was purchased from 
Sigma-Aldrich.  
 Construction and in vivo evaluation of mutants. The truncated, monofunctional N-
terminal region of P-protein chrorismate mutase described by Ganem and co-workers15 
was previously isolated and fused to a self-cleavable chitin binding domain-intein fusion 
construct (IMPACT-CN, New England Biolabs).31 Site-specific variants were produced 
in this construct by using single oligonucleotides with degenerate codons in combination 
with the Quikchange multi-site mutagenesis kit (Stratagene). DNA was prepared directly 
from plated colonies after transformation of XL10-gold cells (Stratagene) and 
subsequently used to transform KA12 pKIMP-UAUC.  Cells were plated on both 
selective and non-selective M9c minimal agar plates, prepared as described32 except that 
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20 μg/mL L-Phe was included in the selective plates. Non-selective plates contained both 
L-Phe and L-Tyr. To allow identification of active variants, mutagenesis reactions made 
use of inactive templates (i.e., stop codons in the position of interest) and colonies that 
were viable on selective media were selected for sequencing. For identification of 
inactive variants, reactions were performed using a wild-type template; colonies that were 
nonviable when picked onto selective media plates were sequenced. To speed 
identification of the remaining variants, non-degenerate and less-degenerate mutagenesis 
reactions were performed. All reported constructs were verified by DNA sequencing. 
Biological activity or inactivity was confirmed by retransformation and plating. 
 The possibility was investigated that disruption of activity might be caused by 
deleterious mutations to the promoter region or the N-terminal gene fusion rather than by 
mutation of the enzyme itself. For some inactive variants, evidence against spurious 
mutation was provided by multiple independent occurrences of the same mutation with 
identical behavior.  For remaining inactive variants, expression of appropriately sized 
constructs was verified with small-scale cultures followed SDS-PAGE analysis. 
Frameshifts or deletions within the N-terminal gene fusion would have been readily 
apparent. 
 Protein expression and purification. Proteins were expressed in E. coli BL21 
DE3, with induction at room temperature using 1 mM IPTG. Cell lysis utilized an 
Emulsiflex-C5 (Avestin) and was conducted in a buffer containing 20 mM Tris, pH 8, 
500 mM NaCl, 1mM EDTA, 10 mM MgCl2, and DNase, RNase, and PMSF. Affinity 
purification using chitin agarose (New England Biolabs) was performed according to the 
IMPACT-CN kit protocols. Affinity tag self-cleavage was induced with 50 mM DTT at 
25° C.  Mass spectrometry and SDS-PAGE previously indicated that this procedure 
results in the desired EcCM construct.31 Proteins were further purified by gel filtration 
using 50 mM Tris pH 7.8, 100 mM NaCl. A well-resolved dimer peak was collected, and 
variants with significant higher-order aggregation were not further considered. Because 
the natural CM enzymes are considerably larger in size and do not have the affinity tag, 
affinity purification followed by gel filtration should have eliminated any significant 
catalytic contribution of natural enzymes. Protein concentration was determined by 
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Bradford assay using BSA as a standard for consistency with previously published kinetic 
studies of the same construct.21,31,33 
 CD spectrometry and thermal denaturation. All variants showed nearly 
superimposable far-UV circular dichroism wavelength scans at the activity assay 
temperature of 37° C. Thermostabilities were assessed by thermal denaturation monitored 
monitored with an Aviv 62DS circular dichroism spectrometer equipped with 
thermoelectric temperature control. CD was followed at 222 nm over a range of 15-99°C. 
Temperature steps of 1°C were used with averaging times of 30 sec. and equilibration 
times of 90 sec. Buffer containing 50 mM Tris pH 7.8, 100 mM NaCl was used.  
Midpoints of thermal denaturation (Tm) were obtained by fitting data to a two state 
model34. It should be noted that unfolding was not reversible and some samples showed 
clear evidence of non-two-state behavior, so Tm values should be taken as estimates of 
relative stabilities rather than thermodynamic parameters. CD data were collected at 22 ± 
3 μM protein. Variations in Tm from different concentrations within the range were 
similar to variations across multiple trials. 
 Kinetic assays. The absorbance of chorismate was followed at 275 nm ( = 2630 
M-1 cm-1 (3)) to obtain intital reaction rates. Activity assays were performed at 37 °C in 
50 mM Tris pH 7.8, 2.5 mM EDTA, 20 mM -mercaptoethanol, and 0.01% BSA, 
conditions used in prior studies of the same construct.21,31,33 Given pKas for chorismate 
and prephenate of < 4.5,
35
 these conditions ensure that the reaction of chorismate
2-
 to 
prephenate
2-
 was monitored. A protein concentration of 20 nM was generally used, 
however, less-active variants were assayed with 40 nM or 100 nM protein. For cases 
where kcat and KM are reported, at least three trials with 9 or more data points each were 
performed, and substrate concentration ranges of at least 0.3-3 times KM were used. 
Kinetic parameters were determined by non-linear fitting of the buffer-corrected initial 
rates to the Michaelis-Menten equation.  
 
Results and Discussion 
 Tolerance to mutation. We tested the effect of all possible single mutations to five 
hydrophobic amino acid residues of the monofunctional E. coli P-protein chroismate 
mutase (Table 1). Each variant was tested for its ability to promote growth in the KA12  
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Table 1. Results for complementation tests, kinetic parameters, and thermal stabilitiesa 
pos 7 k cat K M k cat/K M T m pos 81 k cat K M k cat/K M T m
ALA - ALA -
ARG - ARG -
ASN - ASN -
ASP - ASP -
CYS + > 750 0.6 52.0 CYS + aggr
GLN - GLN -
GLU - GLU -
GLY - GLY -
HIS - HIS -
ILE + 2188 ± 95 298 ± 82 7.3 65.8 ILE + 2330 ± 310 304 ± 52 7.7 61.4 ± 0.6
LEU + 2330 ± 310 304 ± 52 7.7 61.4 ± 0.6 LEU + > 750 3.3 57.7
LYS - LYS -
MET + > 750 2.6 60.3 MET + 1610 ± 120 271 ± 23 5.9 64.6
PHE + 2900 ± 140 350 ± 28 8.3 62.3 PHE + > 750 0.5 59.0
PRO - PRO -
SER - SER -
THR + > 750 0.8 59.2 THR -
TRP - TRP + aggr
TYR - TYR -
VAL + 2140 ± 190 720 ± 110 3.0 61.9 VAL + aggr
pos 32 k cat K M k cat/K M T m pos 85 k cat K M k cat/K M T m
ALA + 2330 ± 310 304 ± 52 7.7 61.4 ± 0.6 ALA + > 750 0.7 62.7
ARG - ARG + > 750 2.5 66.9
ASN - ASN + > 750 0.7 66.8
ASP - ASP -
CYS + ppt CYS + 1890 ± 240 568 ± 87 3.3 54.7
GLN - GLN -
GLU - GLU -
GLY + aggr GLY -
HIS - HIS -
ILE + ppt ILE + 3313 ± 64 550 ± 34 6.0 62.9
LEU - LEU + > 750 2.6 62.2
LYS - LYS + > 750 0.8 67.1
MET - MET + > 750 0.9 65.6
PHE - PHE + > 750 1.2 61.7
PRO - PRO -
SER + 2710 ± 360 220 ± 29 12.4 61.7 SER -
THR + 3630 ± 240 384 ± 69 9.4 62.8 THR + > 750 1.3 62.1
TRP - TRP + aggr
TYR - TYR + > 750 1.6 65.7
VAL + ppt VAL + 2330 ± 310 304 ± 52 7.7 61.4 ± 0.6
pos 35 k cat K M k cat/K M T m
ALA + 1220 ± 120 515 ± 86 2.4 61.2
ARG -
ASN -
ASP -
CYS + 1115 ± 36 358 ± 37 3.1 61.8
GLN -
GLU -
GLY -
HIS -
ILE + 3900 ± 510 441 ± 82 8.8 66.6
LEU + > 750 0.8 66.7
LYS -
MET + > 750 3.1 68.9
PHE -
PRO -
SER -
THR + > 750 1.2 56.5
TRP -
TYR -
VAL + 2330 ± 310 304 ± 52 7.7 61.4 ± 0.6
 
a kcat in μM/min; KM in μM; kcat/KM in min
-1 μM-1. Tm in °C. Notes: aggr/ppt, protein aggregated or precipitated during 
purification. Where uncertainties are indicated, averages and standard deviations are reported from at least three trials. 
Where KM was larger than 750 min
-1μM-1, kcat/KM represents an estimate from a single trial. 
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pKIMP-UAUC chorismate mutase deletion system,20,30 which requires chorismate mutase 
activity for viability in media lacking tyrosine and phenylalanine. Of the 95 possible 
single mutants, 35 (or 37%) were scored as active. Although it is difficult to compare 
results across systems given likely variations in cellular requirements, protein expression 
levels, and various other factors, this value is consistent with other extensive substitution 
experiments. A sampling from among the many exhaustive and random mutagenesis 
studies suggests that between 50% and 85% of single mutations typically maintain some 
level of function.36-41  In catalytic sites, an average of 20%-60% of single mutations 
preserve some function.41-44 Thus, the hydrophobic residues studied here have an average 
tolerance to substitution typical of active site residues in other proteins.  
 EcCM variants that allowed growth on selective media were purified and their in 
vitro stabilities and kinetic parameters were evaluated. Measured Tm values for 
biologically active variants ranged approximately ±10 °C relative to wild type, yet the 
average Tm (61.7° C) was similar to that of the wild type (61.4° C). In vitro activities were 
reduced relative to wild type, except in a few cases. The greatest increase in activity 
relative to wild type was found with the Ala32Ser mutation, previously reported as the 
result of a computational design approach.31  This mutation results in an approximately 
60% increase in catalytic efficiency with minimal change in stability.    
 Position 7. Leu7 lies near the enolpyruvyl moiety carboxylate and also the 
catalytically essential residue Arg11. Position 7 tolerated six relatively conservative side 
chain substitutions, with mutations to Ile and Phe offering slight increases in stability and 
Phe leading to slightly higher activity.  
 Position 32.  Ala32 lies closest to the equivalent of the forming C-C bond and the 
cyclohexadienyl face carboxylate in the transition state analog of the 1ecm structure. 
Although six alternate side chains were tolerated in position 32, only the Ala32Ser and 
Ala32Thr variants could be readily purified without precipitation or aggregation. These 
substitutions increased catalytic efficiency slightly.   
 Position 35. In the 1ecm structure, Val35 is within van der Waals contact distance 
of the catalytically important residues Lys39 and Gln88, both of which contact the ether 
oxygen of the breaking bond.  Val 35 also is expected to pack against the face of the 
enolpyruvyl moiety in the reacting molecule. Six mutations were tolerated in this 
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position.  The Val35Met, Val35Leu, and Val35Ile mutations increased Tm by 7.5° C, 5.3° 
C, and 5.2° C, respectively. All mutations decreased catalytic efficiency except for 
Val35Ile, and all mutations increased KM.  
 Position 81. In the 1ecm crystal structure, Ile81 packs closely against the 
cyclohexadienyl face carboxylate of the transition state analog.  Six substitutions of this 
residue were tolerated, although the cysteine, tryptophan, and valine mutants were prone 
to aggregation in vitro.  Aside from a slight increase in stability with the Ile81Met 
mutation, the substitutions for which data could be obtained led to reduced stability and 
catalytic efficiency.  
 Position 85.  Based on the 1ecm structure, Val 85 lies adjacent to Ile81 and close 
to the cyclohexadienyl face of the reacting.  The C-C vector of Val85 is directed more 
towards solvent than Ile81; consistent with this orientation, the residue was broadly 
tolerant of substitution, allowing 12 of 19 possible mutations.  Interestingly, 9 of the 11 
mutants for which data were recorded showed increased Tm relative to wild type, while all 
of the mutants had increased KM. 
 Comparison to AroQ family members.  Table 2 shows structural equivalents from 
other solved AroQ mutase structures of each of the five residues investigated.  A 
structural alignment was performed for each structure and sequence variations are 
reported from a BLAST45 search of the RefSeq database46 using the sequence from that 
structure as a query. A number of the observed sequence changes from other organisms 
were found to retain wild-type-like or have increased activity in the EcCM scaffold: 
Leu7Ile, Ala32Ser, Ala32Thr, and Val35Ile.  Four mutations were observed in sequence 
alignments but led to precipitated or aggregated protein in vitro: Ala32Val, Ala32Gly, 
Ala32Cys, and Ile81Val.  The majority of variations from sequence alignments led to 
reduction in activity or loss of biologically sufficient activity, however.  
Table 2.  Active site alignment of solved AroQ mutase structures and BLAST resultsa 
E. coli; 1ecm Leu 7 Ala 32 (STV) Val 35 (I) Ile 81 (L) Val 85 
S. cerevisiae; 4csm Leu 12 Gly 161 Val 164 Ile 239 (M) Lys 243 
M. tuberculosis; 2fp2 Leu 130 Ala 53 Val 56 (IM) Ile 102 Glu 106 (KV) 
P. furiosus; 1ybz Leu 4  Ala 29 (CS) Ile 32 (M) Leu 67 (V) Lys 71 (R)  
T. thermophilus; 2d8d Ile 5 (LM) Val 30 (A) Ile 33 (V) Phe 78 Leu 82 (T) 
aProteins were aligned over the transition state analog or over all residues. For each pdb protein sequence, 
protein-protein BLAST44 was performed using the RefSeq database45. Variations of the position are 
reported in parentheses for matches with bitscores of 85 or greater (60 for 1ybz); these scores corresponded 
to sequences with ~40% sequence identity or greater. 
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 The sequence alignments reflected the tolerance to mutation seen in position 85. 
Related organisms showed identities including Glu, Lys, and Arg, in accord with the 
more solvent-directed orientation of this position. A previous selection study reported 
that the equivalent of position 85 in Methanococcus jannaschii CM was highly 
conserved.47 However, that observation may reflect interactions not present in the E. coli 
structure. The equivalent position in the M. jannaschii enzyme is expected to be occupied 
by a lysine that forms a salt bridge with a residue from a neighboring helix in crystal 
structures.11  Curiously, the equivalent of position 85 in the Mycobacterium tuberculosis 
enzyme makes a catalytically important contact to the hydroxyl group of the transition 
state analog that EcCM makes with Glu52.11 
 Tradeoff between stability and activity. It has been proposed that evolutionary 
optimization of active site residues for catalysis would result in the selection of residues 
that are not optimal for protein stability.25-29  Enzymes must devote stabilizing interactions 
to the reacting molecule that are left both unsatisfied and likely destabilizing in the 
unbound form of the protein. A laboratory-evolved chorismate mutase of Kast, Hilvert, 
and co-workers dramatically illustrated this principle by transforming from an apparent 
molten globule into a more ordered protein in the presence of a transition state analog.48,49 
 The results presented here are consistent with the idea of a stability-activity 
tradeoff in enzyme active sites. Of the biologically active variants, sixteen showed 
increased stability, while eleven showed decreased stability. In position 85 of EcCM, all 
of eleven biologically active mutants showed reduced catalytic efficiency and increased 
KM and nearly all mutants showed increased thermostability. Val85 participates in van der 
Waals interactions with both the transition state analog and residues from neighboring 
helices in the 1ecm structure.  Thus, stability could potentially be increased and 
chorismate affinity could be reduced through substitutions that partially fill the binding 
pocket, through helix-helix interactions that affect the geometry of the active site, or 
through a combination of the factors. Movement of the neighboring helix has been 
propsed to facilitate substrate entry11 and helix-helix interaction could affect substrate 
affinity or cause substrate entry to impact the rate-limiting step. In position 35 as well, all 
biologically active mutations had increased KM and a few showed large increases in 
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thermostability. In the 1ecm structure, Val35 appears to participate in van der Waals 
interactions with the transition state analog, catalytically important residues Lys39 and 
Gln88, and neighboring helix residues. While the present study cannot be expected to 
isolate the relative contributions of these different interactions, it clearly indicates that 
this residue contributes to the catalytic process and the global stability of the protein. 
 Relationship to models of EcCM catalytic mechanism. Among theorists, differing 
computational treatments of chorismate mutase systems have led to varied descriptions of 
the origin of enzymatic catalysis of the rearrangement. Despite an observation that the 
chemical step is not fully rate limiting in the enzyme,16 the majority of work has modeled 
the BsCM active site.50-68 The few computational investigations in the monofunctional 
EcCM construct have proposed, in opposition to most of the other studies, that both 
enzymes accelerate the rearrangement exclusively by restricting the conformational space 
of the substrate, not by stabilizing the transition state.59,69-71 While these studies, and an 
earlier one,72 explicitly identified Val35 and Ile81 as mediators of the substrate 
restriction, we do not expect the mutations identified here to differentiate between 
possible modes of EcCM catalysis.  
 For example, the Val35Ile mutation led to an increase in kcat and the Val35Ala 
mutation led to decreased kcat. While these mutations would be expected to reduce and 
increase the conformational freedom of the bound substrate, respectively, the changes in 
kcat are relatively small and could be attributed to any number of factors. In addition to its 
close proximity to the reacting molecule, Val35 is within van der Waals contact distance 
of catalytically essential Lys39 and a number of other residues. Perturbations to any of 
these interactions could have consequences for the geometry and energetics of critical 
hydrogen bonds, leading to changes in relative stabilization in the transition state. Simple 
continuum electrostatics calculations suggest that these mutations could also lead to small 
changes in electrostatic potential at the reacting molecule. In short, hydrophobic active 
site residues perform essential functions in active sites, but it is difficult to isolate their 
precise effects on catalysis.     
 Implications for enzyme design.  The present mutational study was conducted to 
clarify the results of a previous computational design experiment.31 Computational design 
procedures73 were used to model an ab initio calculated transition state structure for the 
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rearrangement within the EcCM active site. Eighteen residues were designed, and the 
energy function selected for mutation only the five hydrophobic positions of the present 
study and Asp48. The replacement of Asp48 led to a loss of catalytic activity; this 
position is being further investigated with the aim of improving design models. 
 The results presented here suggest that current computational design methods are 
able to reasonably model hydrophobic side chains in enzyme active sites. The mutations 
selected in the previous study, Leu7Ile, Ala32Ser, Val35Ile, Ile81Leu, and Val85Ile, were 
all scored as biologically active and most performed well in terms of in vitro activity and 
stability.  The availability of a large dataset for single mutations in these positions will 
enable evaluation and tuning of enzyme design energy functions in more detail. 
 Finally, the ability of EcCM to tolerate a number of mutations without reduction 
in stability or activity is in accord with previous descriptions of active site plasticity. 
Secondary active site residues that accept side chain substitutions can allow evolution or 
design of enzymes with new substrate specificities and chemical mechanisms, sometimes 
without disruption of the original function.74-77 These secondary positions offer rich 
opportunities for testing and refining enzyme design methodologies through active site 
redesign experiments.  
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Chapter 5 
 
 
Importance of a Helix N-Capping Residue for Stability and 
Catalytic Activity of Escherichia Coli Chorismate Mutase 
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purification and analysis of proteins.  
 
 
 
 
 
 
 
Abstract  
 A helix N-capping residue in the monofunctional E. coli chorismate mutase 
enzyme has been investigated to evaluate the importance of this residue to catalytic 
activity.  This residue, Asp48 in the wild-type enzyme, simultaneously interacts with the 
helix N-terminus and an arginine side chain that is critical for catalytic activity. We 
investigated the effect of all 19 mutations in this position on in vivo activity. Four 
variants were found to have biological activity. In vitro kinetics and thermal stabilities 
were measured for these four variants.  All showed reduced activity and thermostability.  
Because computational design tests suggest that modeling in this position is not reflective 
of the observed requirements for catalytic activity, we are further investigating the role of 
this residue in catalysis and substrate binding. 
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 The N- and C-termini of -helices are flanked by residues with distinct 
preferences for side chains that can satisfy unpaired helical hydrogen bond donors and 
acceptors.1-3 These helix-capping interactions are reflected in protein database surveys, 
protein stability measurements, and model peptide studies (reviewed in ref. 4). At N-
termini, N-cap residues can affect helix stability by as much as 4 kcal/mol5 and are found 
to be important considerations in protein design.6 
 We report an investigation of an N-capping residue in the active site of an 
important model enzyme and find that the residue is essential for efficient catalytic 
efficiency.  
 Chorismate mutases catalyze the rearrangement of chorismate to prephenate (Fig. 
1), a key step in the biosynthesis of aromatic products including tyrosine and 
phenylalanine. The reaction is a Claisen rearrangement, a concerted [3,3]-sigmatropic 
process, and proceeds through a chairlike transition state in enzyme and solution.7-11 
Chorismate mutases from Escherichia coli are fused to prephenate dehydratase or 
prephenate dehydrogenase to form bifunctional enzymes,12 but truncated, monofunctional 
mutase constructs have been used for mechanistic and structural studies.11,13,14  
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chorismate prephenate  
Figure 1.  The Claisen rearrangement of chorismate to prephenate. 
 
 The chorismate mutase domain of E. coli chorismate mutase-prephenate 
dehydratase (EcCM) is a homodimeric helix bundle with residues from both chains 
forming each active site (Fig. 2A).14 The N-capping residue Asp48 hydrogen bonds with 
both the helix N-terminus and Arg11, a critical residue that contacts the transition state 
analog in crystal structures (Fig. 2B). Mutational studies have shown the importance of 
Arg11 to catalysis; the Arg11Lys and Arg11Ala mutants lead to 103-fold and 104-fold 
reductions in catalytic efficiency, respectively.15 
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Figure 2. The N-terminal 109 residues of E. coli chorismate mutase-prephenate 
dehydratase, from pdb code 1ecm (A) The two chains in the homodimer are colored 
differently and the crystallographic transition state analog is shown with spheres. (B) 
Interactions of Asp48 with helix N-terminus and Arg11, shown contacting the transition 
state analog. Side chains, protons, and other elements are neglected for clarity. 
 
 
 We tested the effect of all 20 amino acids in position 48. Each variant was 
assessed for its ability to complement the E. coli chorismate mutase deletion strain of 
Kast, Hilvert, and co-workers,16,17 which requires chorismate mutase activity for growth 
on media lacking tyrosine and phenylalanine. Variants showing in vivo mutase activity 
were expressed and purified, and their in vitro kinetic parameters and thermal stabilities 
were evaluated. Table 1 shows the results of complementation tests, kinetics, and thermal 
denaturation. 
All but four position 48 mutants (Leu, Asn, Gln, and Cys) lost complementation 
capability, and these four variants showed significant reduction in both Tm and kcat/KM.  
All four mutants showed significant increases in KM such that kcat and KM could not be 
determined accurately using the assay procedure. While the Tm values reported in this 
study should be viewed as approximate measures of stability because thermal 
denaturations were not reversible, the four Tm values were reduced 4-8 °C relative to wild 
type. 
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Table 1. Results from in vivo complementation, thermal denaturation, and kinetic assays
a 
pos 48 kcat KM kcat/KM Tm 
ALA -     
ARG -     
ASN +  >  750 0.5 56.5 
ASP + 2330 ± 310 304 ± 52 7.8 61.9 
CYS +  >  750 1.1 53.8 
GLN +  >  750 0.6 55.5 
GLU -     
GLY -     
HIS -     
ILE -     
LEU +  >  750 0.4 57.7 
LYS -     
MET -     
PHE -     
PRO -     
SER -       
THR -     
TRP -     
TYR -     
VAL -         
a kcat in μM/min; KM in μM; kcat/KM in min
-1 μM-1. Tm in °C. 
 
 
The fact that all position 48 mutants lost stability coincides with previous studies 
placing Asp as one of the most favored N-capping residues.3,18,19  However, the ordering 
of stabilities of the five biologically active variants, Asp > Leu > Asn > Gln > Cys, 
differs somewhat from the observed trends, which would rank Leu lower in stability than 
Asn or than Cys, depending on the study.   
The interaction of Asp48 with Arg11 in the EcCM crystal structure (Figure 2B) 
suggests that the Asp48 side chain occupies an ideal geometry for simultaneous 
stabilization of the helix and the essential catalytic residue. The simplest explanation for 
the loss of activity is that the salt bridge is required to stabilize the arginine in a geometry 
that provides for optimal interaction with the reacting molecule. However, more complex 
processes could be involved. The Asp48-Arg11 salt bridge spans the interface between 
two helices proposed to offer the site of entry of substrate into the binding pocket.  
Structural studies on related enzymes20 suggest that the two helices may be able to move 
relative to each other, opening an entry pathway. If this model is correct, it suggests that 
the Asp48-Arg11 interaction could impact the process of substrate entry into the binding 
pocket.  
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As discussed further in chapter 6, tests of computational enzyme design methods 
suggest that the effects of position 48 on catalytic activity are not being modeled 
accurately. Thus, we are further investigating the role of this position with the hope of 
determining how the interactions of position 48 affect substrate binding and catalytic 
activity. 
 
Materials and Methods 
 
Mutagenesis and in vivo evaluation of mutants 
The truncated monofunctional E. coli chorismate mutase13 was previously inserted into a 
self-cleavable affinity expression system from the IMPACT-CN kit (New England 
Biolabs).21 All amino acid mutations in position 48 were constructed using the 
Quikchange multi-site mutagenesis kit (Stratagene). Both degenerate codon and non-
degenrate oligos were used to speed the process of identifying mutants. Each mutant was 
tested for viability in chorismate mutase deletion system KA12 pKIMP-UAUC16,17 using 
M9c minimal agar plates as described22 except that 20 μg/mL L-Phe was included in the 
selective plates (non-selective plates contained both L-Phe and L-Tyr).  Small-scale 
expression and SDS-PAGE for all variants verified that appropriately sized constructs 
accumulated following induction with IPTG.  
 
Protein expression and purification 
Expression and purification followed previously described procedures21. After 
overexpression in E. coli BL21 DE3, affinity purification and self-cleavage according to 
the IMPACT-CN protocol was followed by gel filtration in 50 mM Tris pH 7.8, 100 mM 
NaCl. Protein concentration was determined by Bradford assay using BSA as a standard 
for consistency with previous experiments.21,23,24 
 
Thermal denaturation 
Denaturation was monitored with an Aviv 62DS circular dichroism spectrometer 
equipped with thermoelectric temperature control. CD was followed at 222 nm over a 
range of 15-99°C.  Temperature steps of 1°C were used with averaging times of 30 sec. 
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and equilibration times of 90 sec. Samples contained 20 μM protein in 50 mM Tris pH 
7.8, 100 mM NaCl. Midpoints of thermal denaturation (Tm) were obtained by fitting data 
to a two-state model.25 Tm values should be construed as approximate measures of 
thermostability, as the denaturation was not a reversible process. 
 
Kinetic assays 
The absorbance of chorismate was followed at 275 nm ( = 2630 M-1 cm-1).7 Assays were 
performed at 37°C. Protein concentrations of 20 nM, 40 nM, or 100 nM were used in 50 
mM Tris pH 7.8, 2.5 mM EDTA, 20 mM -mercaptoethanol, and 0.01% BSA. Where kcat 
and KM are reported, substrate ranges of at least 0.3-3 times KM could be tested, and three 
trials were performed with 9 or more points each. Kinetic parameters were determined by 
non-linear fitting to the Michaelis-Menten equation. 
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Chapter 6 
 
 
 
Perspectives on Computational Enzyme Design from Mutational 
Studies and Attempted Design of a New Chorismate Mutase 
 
 
 
 
 
 
 
 
 
 
 The major objective of this thesis research was to design a completely new enzyme 
to catalyze the Claisen rearrangement of chorismate to prephenate. Following the same 
process as described in Chapter 2, computational protein design methods were used to 
optimize side chains around an ab initio calculated transition state structure1 for the 
chorismate-prephenate rearrangement. Instead of performing designs on a natural enzyme 
as in the experiments described so far, a series of protein scaffolds were selected that had 
no existing chorismate mutase activity.  Roughly eighteen protein scaffolds were 
investigated, a large number of individual protein variants were purified and characterized, 
and variant protein libraries were constructed through error-prone PCR, gene synthesis, and 
degenerate codon mutagenesis. Both in vitro assays and the in vivo selection system of 
Kast, Hilvert, and co-workers2,3 were used to test for activity. Ultimately, no designed 
protein catalyzed the rearrangement. What follows is not a complete analysis of the efforts, 
but simply an anecdotal discussion of some of the lessons that were learned from both the 
de novo design effort and from the mutational studies described in Chapters 3, 4 and 5. 
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Computational design methods performed well with many natural enzyme residues 
 
 As described in detail in Chapters 2 and 3, the computational design process was 
able to recover the geometrical configuration of the wild-type E. coli chorismate mutase 
active site and the critical side chains known to be required for catalysis. This is not 
surprising, given that the calculations were designed to look for active site configurations 
with geometries similar to those seen in the wild type. Yet the reproduction of the natural 
active site represents a necessary first step in being able to identify enzyme-like 
configurations within other scaffolds. 
 The test calculation described in Chapter III yielded six mutations in secondary 
active site positions—residues that are not known to be essential for catalysis.  When these 
mutations are compared to the results from exhaustive mutagenesis performed in Chapters 
4 and 5, it becomes clear that some residues were modeled quite successfully, even though 
the wild-type residue was not recovered.  Table 1 shows a summary of these findings. 
Mutations in four positions led to increases in activity and/or stability relative to wild type, 
with three of the predicted mutations found to be the most stable or most active of the 
possible substitutions. Mutations to two positions led to reduced activity.  Most of the 
changes were relatively small in magnitude, corresponding to changes in energy of 
activation of less than 1 kcal/mol.  Only position 48 showed a loss of activity of multiple 
orders of magnitude. These results are encouraging, suggesting that out of 18 residues 
designed, only one position presented serious problems in modeling the wild-type enzyme.   
 
Table 1.  Summary of positions mutated in EcCM computational design experiment 
Variant Change in Stability Change in Activity 
Leu7Ile 
4.4° C more stable than wild type; the most 
stable variant in that position. 
Activity maintained within error 
Ala32Ser Stability maintained within error 
59% increase in catalytic efficiency; the 
most active variant in that position. 
Val35Ile 5.2° C more stable than wild type 
13% increase in catalytic efficiency; the 
most active variant in that position 
Asp48Ile n.d. Reduced activity significantly 
Ile81Leu Reduced stability 3.7° C Reduced activity 40% 
Val85Ile 1.5° C more stable than wild type 40% increase in kcat; efficiency reduced 
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Inadequacies of the model may lead to significant problems in some positions 
 
 As described above and in Chapters 3 and 5, the Asp48Ile mutation led to a 
dramatic loss of catalytic activity. While the exact reduction in activity was not quantified, 
results from the assay procedure suggest that the reduction was greater than 103-fold. 
Asp48 simultaneously caps the helix N-terminus and interacts with an arginine side chain 
that is critical for catalysis (Figure 1). While it is disturbing that the energy function would 
choose isoleucine in a position that clearly requires an N-capping interaction, this 
discussion will focus specifically on implications for catalysis. A loss in stability would 
have been expected, but the impact of loss of the Arg11-Asp48 salt bridge on catalytic 
activity is perhaps less obvious. A predicted structure of the Asp48Ile variant suggested 
that the interactions of solvent and neighboring side chains could continue to stabilize the 
desired conformation of Arg11 and the Ile48 side chain would not likely destabilize the 
reacting molecule. As demonstrated in Chapter 5, however, all mutations in position 48 led 
to reduced catalytic activity and increased KM.  
 
 
Figure 1. Asp48 caps the helix N-terminus while forming a salt bridge with catalytically essential Arg11 
(shown contacting the crystallographic transition state analog). 
 
 As discussed in Chapter 5, the loss of the Asp48-Arg11 salt bridge may affect 
activity by leading to a loss of precision in the positioning of Arg11 for interaction with the 
reacting molecule or by allowing the Arg11 side chain to reorient towards solvent. 
Alternatively, it could impair the substrate entry process and cause substrate binding to 
impact the rate-limiting step. The available data do not allow us to distinguish between 
these or other possibilities. However, one thing is certain—a protein design model that 
optimizes for global stability in a single state does not account for these complex effects. 
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The inadequacy of the model for dealing with position 48 is illustrated in Figure 2, where 
calculated energies for all 20 position 48 variants are plotted against experimental catalytic 
efficiencies.  These calculations were performed using a standard energy function and the 
methods outlined in Chapter 2.  An ab initio calculated transition state structure was 
superimposed with the crystallographic transition state analog and then allowed to translate 
and rotate within the binding pocket. Regardless of whether the total energy of the system 
or the energy of the transition state structure is plotted, the majority of the variants are 
assigned lower energies than Asp48. While a linear correlation would not necessarily be 
expected given known limitations in protein design methods, the fact that the only efficient 
enzyme, the wild type, was ranked as one of the highest-energy amino acids is certainly 
cause for concern. Repulsion of the charged Asp side chain with the carboxylate of the 
reacting molecule results in unfavorable electrostatic energy.  Perhaps more importantly, 
the model is not sophisticated enough to register any favorable effect that the Asp side 
chain might have on the reacting molecule indirectly through its interaction with the 
arginine. Relevant elements that are completely neglected in the calculation include the 
side-chain entropy of the arginine, polarization effects, orientations of the substrate and 
side chains in the unbound state, dynamics of the substrate entry process, and changes in 
backbone structure resulting from loss of the N-capping interaction.  
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Figure 2. Calculated energies do not correlate with activity in position 48 variants. Calculated energies (using 
standard design force field) are plotted against experimental catalytic efficiencies for all 20 position 48 
variants. Catalytic efficiencies of biologically inactive variants are set to zero. Wild-type Asp48 is the single 
data point with high catalytic efficiency (kcat/KM). (A) Total calculated active site energies. Includes 
contributions from all side chain, backbone, and TS structure interactions within the active site. Normalized to 
the wild-type energy. (B) Interaction energies of TS structure with side chain and backbone elements in the 
active site only. Normalized to the wild-type energy. 
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Selection of robust starting scaffolds is critical for design 
 
 At one point during the efforts toward attempted design of a new chorismate 
mutase, a structure-based approach to scaffold selection was tested. A computational 
procedure was developed to search the Protein Data Bank for protein scaffolds containing 
binding sites similar in volume and shape to that of E. coli chorismate mutase. One of the 
structures identified was an enzyme with a TIM barrel fold that had some similarities in 
active site geometry and electrostatics to the natural chorismate mutase active sites. 
Because design calculations yielded favorable results, designed proteins based on this 
scaffold were constructed and experimentally evaluated. 
 The wild-type protein was purified in good yield from the soluble cell fraction and 
showed all evidence of normal folding behavior by circular dichroism. However, a 
designed active site variant of the scaffold, a 10-fold mutant, was found primarily in the 
insoluble cell fraction following lysis and centrifugation. Changes in the expression 
temperature and protocol yielded no improvement of solubility, and refolding attempts 
under a variety of conditions failed. To investigate how seriously the design mutations 
affected the expression properties of the protein, a minimal design with 5 mutations was 
constructed.  This variant was found to express in the insoluble fraction, as were single and 
double mutations of the wild type.  
 
Sol. Insol. Sol. Insol. Sol. Insol.Sol. Insol.
Minimal 
design:
5 mutations
Sol. Insol.
Design:
10 mutations
double
mutant
single
mutant
single
mutant
 
 
Figure 3. Although the wild-type TIM barrel expressed in the soluble fraction with good yield and appeared 
well folded by circular dichroism, both computationally designed variants and minimal versions thereof were 
found in the insoluble cell fraction. SDS-PAGE gels are shown, with cell extracts loaded as indicated. Sol., 
soluble cell fraction; Insol, insoluble cell fraction. 
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 The scaffold was originally selected because of similarity with natural chorismate 
mutase active sites in hopes that conservation of existing active site elements would 
minimize disruption. However, the scaffold ultimately was not able to accommodate even 
single mutations to the active site. Future efforts utilized a monomeric TIM barrel from a 
hyperthermophilic organism, which proved to be much more tolerant to mutation. This 
experience underscores the importance of identifying a robust starting scaffold for active 
site redesign, even at the cost of potentially making more mutations.  
 
 
Enzyme design is a difficult task 
 
 At least a million variants were screened in the present effort to design a new 
chorismate mutase and no active enzyme was found. A graduate student who continued to 
construct individual designed molecules at the rate that they were made in the early years 
of this thesis research might be better off waiting for natural evolution to produce the new 
enzyme. The probability of a single design having catalytic activity will always be less than 
one, and in many cases it will be less than one in a million. Accordingly, it makes sense to 
construct and screen large libraries of designed variants rather than testing individual 
designs. Enzyme design efforts during the later years of this thesis research took this 
approach, combining the strengths of computational design and directed evolution 
methods. Powerful approaches have been developed for construction and evaluation of 
gene libraries4-8 and the combination of computational design and directed evolution9-11 will 
likely yield many successful new enzymes in the future. 
 Even with the combined computational design and directed evolution approach, an 
unfortunate consequence of work on this difficult problem is that a considerable amount of 
effort has been expended and yet relatively little understanding has been gained. A large 
number of computationally designed proteins have been constructed and evaluated for their 
ability to catalyze a reaction. In no case was any measurable catalytic activity identified in 
a designed protein.  Because the absence of catalytic activity provides no feedback about 
energy functions, conformational sampling, substrate binding, or transition state 
stabilization, we are left without any understanding of what might have gone wrong and no 
pathway for improvement. 
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 In planning future projects, those attempting computational enzyme design would 
benefit from taking the time to develop systems that can provide experimental feedback 
through intermediate steps. Clearly, the binding of a substrate or transition state analog 
represents a first step to enzyme development and could be monitored.  In the case of the 
chorismate-prephenate rearrangement, binding of Bartlett’s transition state analog12 has 
been measured with isothermal titration calorimetry.13 If a designed protein does not 
demonstrate some affinity for this inhibitor, it has little hope of becoming a catalyst for the 
rearrangement, even with further optimization by directed evolution. In a new system, 
however, a higher-throughput method would be preferable in order to screen designed 
protein libraries for variants with binding affinity. One would ideally develop creative 
strategies to systematically identify candidates for further optimization based on binding 
and turnover events. The directed evolution literature contains elegant examples of 
techniques applied for these purposes. 
 Another important intermediate step in new design efforts may simply be to 
perform design calculations on natural enzymes that catalyze reactions similar to the target 
reaction. Experiments like those of Chapters II and III could help to clarify appropriate 
ways to model the transition state structure and catalytic side chains in the new system and 
could help to identify major obstacles to accurate modeling. In general, more applications 
of enzyme design to naturally existing enzymes would help to provide reality checks for 
the design field, indicating systematic weaknesses in the methods and providing direction 
for improvement. 
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Appendix A 
 
Evaluation of the Energetic Contribution of an Ionic Network to 
Beta-sheet Stability 
 
 
 
The text of this chapter was adapted from a published manuscript coauthored with 
Deepshikha Datta and Stephen L. Mayo.  
 
Lassila, K. S., Datta, D., and Mayo, S. L. (2002) Evaluation of the energetic contribution 
of an ionic network to beta-sheet stability. Protein Science 11, 688-690. 
 
 
 
 
 
Abstract 
 We have evaluated the interaction energy of a three residue ionic network 
constructed on the beta-sheet surface of protein G using double mutant cycles.  Although 
the two individual ion pairs were each stabilizing by around 0.6 kcal/mol, the excess gain 
in stability for the triad was small (0.06 kcal/mol).   
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 The -sheet surface of the protein G immunoglobulin-binding domain B1 (GB1) 
has been used as a model system for evaluating the -sheet forming propensities of amino 
acids.1,2  These studies, in combination with statistical surveys of known structures and 
theoretical models of -sheet propensity provide some general guidelines for amino acid 
selection in -sheet design.3,4 
An important next step in understanding -sheet stability is to define the role of 
side chain interactions such as hydrogen bonding and ionic interactions.  In particular, the 
energetic effects of surface ionic interactions have been debated.  Solvent exposed ion 
pairs have been found to stabilize folded proteins in a number of cases.5-9  In the context 
of the -sheet surface environment, ion pairs have been reported to stabilize folded 
proteins by 0.4–1.0 kcal/mol.10-12  However, some surface ion pairs exhibit neutral or 
destabilizing effects.13,14  The high dielectric of the aqueous environment and the loss of 
side chain conformational freedom have been invoked to explain the marginal stabilizing 
effects of some pairwise electrostatic interactions.   
Networks of charged surface residues have been observed in hyperthermophile 
proteins and have been proposed to offer an energetic advantage over single ion pairs due 
to the reduced entropic cost of fixing a third residue.14,15 Indeed, two analyses of solvent 
exposed ionic triads in -helical regions have shown that three-residue networks offer a 
stabilizing effect greater than would be observed for the sum of the two individual 
pairwise interactions.6,7 
To test the effect of an ionic triad in the context of the -sheet surface, we have 
evaluated the energetic contribution of a three-residue triad constructed on the -sheet 
surface of GB1.  The network consists of Arg 6, Glu 53, and Arg 44, residues which lie 
on three adjacent strands of the -sheet surface (Figure 1).  Double mutant cycle analysis 
was used to isolate the interaction energy of the triad.16  Eight GB1 variants were 
constructed which represent all permutations of Arg or Ile at position 6, Glu or Ala at 
position 53, and Arg or Ala at position 44.  In this three-residue thermodynamic cycle, 
the interaction energy of the ionic network is calculated as in equation 1. 
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GRERinteraction= {(G
RER-GRAA)-[(GREA-GRAA)+(GRAR-GRAA)]}-                           [1] 
                            {(GIER-GIAA)- [(GIEA-GIAA)+(GIAR-GIAA)]} 
 
GXYZ is the free energy of unfolding for the GB1 mutant with amino acids X, Y, and Z 
at positions 6, 53, and 44, respectively.  The interaction energy of an Arg-Glu ion pair in 
the presence of another residue X is calculated as in equation 2.  
 
GXERinteraction= (G
XER-GXAA)-[(GXEA-GXAA)+(GXAR-GXAA)]                                [2] 
 
Free energies of unfolding (G) were evaluated by two-state analysis of thermal 
denaturation curves monitored by circular dichroism (CD) (Figure 2).   
 
 
Figure 1.  The -sheet surface of GB1 showing possible orientations for side chains Arg 
6, Glu 53, and Arg 44.  In the positions shown, nitrogen-oxygen distances are 2.92 Å  and 
2.85 Å for residue pairs 6-53 and 44-53, respectively.  Side chains were positioned with a 
dead-end elimination algorithm19 and the figure was created with MOLSCRIPT20.  
 
 
 
 The variant containing both a single ion pair and isoleucine, I6E53R44, had the 
highest Tm and G of unfolding (Table 1) while the variant with the ionic triad, R6E53R44 
was only slightly less stable.  It is interesting to note that the addition of the third charged 
residue almost fully compensates for the loss of the -branched (and therefore –sheet 
stabilizing) amino acid. 
 
 
  77 
   
 
Figure 2. Thermal denaturation curves for GB1 variants.  From left to right (at 50% 
unfolded):  R6A53R44, R6A53A44, I6A53R44, I6A53A44, R6E53A44, I6E53A44, R6E53R44, and 
I6E53R44. 
 
 
Table 1.  Stability data for GB1 variants 
                                       Tma                            HTm
b             G (75 °C)c 
Variant                         (°C)                        (kcal/mol)             (kcal/mol) 
R6E53R44                     79.1 ± 0.5                  53.5 ± 2.0                 0.61 
R6E53A44                     76.1 ± 0.4                    52.3 ± 2.0                  0.16 
R6A53R44                     69.6 ± 0.3                   45.0 ± 1.6                 -0.74 
R6A53A44                    70.6 ± 0.3                   46.6 ± 1.5                -0.62 
I6E53R44                      80.1 ± 0.6                    56.1 ± 2.5                 0.79 
I6E53A44                      77.2 ± 0.4                    54.1 ± 1.9                  0.34 
I6A53R44                      75.5 ± 0.3                   50.1 ± 1.5                  0.08 
I6A53A44                      76.0 ± 0.3                   51.4 ± 1.6                  0.14 
aTm, midpoint of thermal denaturation transition  
bHTm, enthalpy of unfolding at Tm  
cG (75 °C), free energy of unfolding calculated at 75 °C  
 
Interaction energies of the Arg6-Glu53 pair were 0.58 kcal/mol in the presence of 
Ala44 and 0.64 kcal/mol in the presence of Arg44 (Table 2).  The Arg44-Glu53 pair had 
interaction energies of 0.51 kcal/mol (in the presence of Ile6) and 0.57 kcal/mol (with 
Arg6).  This level of stabilization is consistent with other surface electrostatic interactions 
studied by double mutant cycles.7,9,10 
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Although the pairwise electrostatic interactions are clearly favorable, the ionic 
network does not appear to significantly enhance GB1 stability any more than the simple 
sum of the individual pairs.  As shown in Table 2, the interaction energy of unfolding for 
the ionic network, Ginteraction, determined at 75 °C (approximately the average Tm for 
the eight variants) was 0.06 kcal/mol.  This very low interaction energy suggests that the 
contributions of the ion pairs are additive; there is no additional stabilization of one ion 
pair in the presence of a third charged residue.  In contrast, previous studies of charged 
networks on -helices using the double mutant cycle method showed stabilizing 
interaction energies of 0.77 kcal/mol for an Asp-Arg-Asp triad6 and 0.65 kcal/mol for an 
Arg-Glu-Arg triad.7  
 
Table 2.  Interaction energies for ion pairs and the three-residue network 
 
                                                 G (75 °C)a                G (75 °C)b 
Interaction                                 Kcal/mol                       Kcal/mol 
R6E53   (A44)                                     0.58 
R6E53   (R44)                                      0.64 
E53R44   (I6)                                       0.51 
E53R44   (R6)                                      0.57 
R6E53R44                                                                                  0.06 
aG (75 °C) interaction energy (calculated at 75 °C) of the ion pair in the presence of 
the residue indicated in parentheses  
bG (75 °C) interaction energy (calculated at 75 °C) of the triad as described in the 
text 
 
The lack of a significant stabilizing interaction energy of the Arg6-Glu53-Arg44 
triad may be due to a variety of factors.  Previously reported factors such as desolvation, 
side chain entropy loss, and conformational strain may counteract the electrostatic 
benefits of the network.  However, the local environment of the triad, including 
secondary structure and neighboring residues, may also affect the magnitude of the 
interaction energy of the triad.  Further studies on -sheet surface electrostatic 
interactions may help to clarify whether or not secondary structure influences the 
stabilizing effect of ionic networks.   
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Materials and Methods 
Mutagenesis and protein expression 
GB1 variants were constructed by inverse PCR mutagenesis and expressed using 
the T7 promoter system as previously described.17  Purification of 57-residue GB1 
variants containing an N-terminal methionine was accomplished by reverse phase HPLC 
and verified by mass spectrometry.  
 
 
 
Thermal denaturation 
The increase in CD signal at 218 nm was followed during thermal unfolding from 
1 °C to 99 °C using 50 μM protein in 50 mM sodium phosphate, pH 5.5.  The midpoint 
of the thermal denaturation (Tm) and the enthalpy of unfolding (H) were determined 
from a two-state analysis of each denaturation curve.1,2  The change in heat capacity upon 
unfolding (Cp) was held constant at 0.621 kcal/K•mol, a value previously reported for 
wild-type GB1.18  G values were assigned using the Gibbs-Helmholtz relation with Cp 
= 0.621 kcal/K•mol.1,2  The average error in calculating G (as determined from curve 
fitting) was 0.06 kcal/mol. 
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Appendix B 
 
Dioxane Contributes to the Altered Conformation  
and Oligomerization State of a Designed Engrailed  
Homeodomain Variant 
 
 
 
The text of this chapter was adapted from a published manuscript coauthored with 
Geoffrey K. Hom, Leonard M. Thomas, and Stephen L. Mayo.  
 
Hom, G. K., Lassila, J. K., Thomas, L. M., and Mayo, S. L. (2005) Dioxane contributes 
to the altered conformation and oligomerization state of a designed engrailed 
homeodomain variant. Protein Science 14, 1115-1119. 
 
 
 
 
Abstract 
 Our goal was to compute a stable, full-sequence design of the Drosophila 
melanogaster engrailed homeodomain. Thermal and chemical denaturation data indicated 
the design was significantly more stable than the wild-type protein. The data were also 
nearly identical to those for a similar, later full-sequence design, which was shown by 
NMR to adopt the homeodomain fold: a three-helix, globular monomer. However, a 1.65 
Å crystal structure of the design described here turned out to be of a completely different 
fold: a four-helix, rodlike tetramer. The crystallization conditions included ~25% 
dioxane, and subsequent experiments by circular dichroism and sedimentation velocity 
analytical ultracentrifugation indicated that dioxane increases the helicity and 
oligomerization state of the designed protein. We attribute at least part of the discrepancy 
between the target fold and the crystal structure to the presence of a high concentration of 
dioxane.
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Introduction 
 The original purpose of this project was to computationally design an amino acid 
sequence that stably adopts the homeodomain fold. The target fold was the same as for 
previous homeodomain designs from our lab,1,2 a 51-residue, crystallographically well-
defined fragment of the Drosophila melanogaster engrailed homeodomain3 (Figure 1). 
This fragment is a globular, three-helix monomer. As in our previous homeodomain 
designs, we did not consider DNA binding but rather focused on protein stability. 
 
Figure 1. Target homeodomain fold for UMC. 
 
 We designed two sequences, UMC and UVF4. UMC was obtained via a Monte 
Carlo algorithm.5 UVF has a slightly lower computed energy and could be obtained via 
either the Vegas6 or the FASTER7 algorithm.  
 UMC and UVF have 79% sequence identity and also have nearly identical 
thermal and chemical denaturation profiles. For both proteins, the melting temperature is 
> 99°C and Gunfolding is 4.2 kcal/mol. The 1D 1H NMR spectra of the proteins display 
the characteristics expected of a monomer, and the NMR-determined structure of UVF 
matches the homeodomain fold.4 
 The above evidence indicated that UMC also adopts the homeodomain fold. 
However, a crystal structure of UMC would give direct confirmation of the overall fold 
and allow for a detailed comparison of crystallographic and computed side-chain 
conformations, which would provide critical data for improving our protein design 
algorithm.8  
 Here we report a 1.65 Å crystal structure of UMC. The structure is a rodlike, four-
helix tetramer (Figure 2), not the expected globular, three-helix monomer. This 
discrepancy could be due to a lack of explicit negative design in our design algorithm; 
however, because of the similarity of UMC to the successful UVF design, we 
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investigated if the crystallographic conditions could be responsible for the discrepancy. In 
particular, the role of dioxane was examined. 
 
 
Figure 2.  Ribbon diagram of the UMC crystal structure. The coloring is cyan (chain A), 
green (chain B), brown (chain C), salmon (chain D), and purple (cadmium). 
 
 
Results 
 The crystal structure of UMC was determined by using single wavelength 
anomalous diffraction (SAD). Crystallographic statistics are shown in Table 1. The 
asymmetric unit contains four UMC molecules forming an anti-parallel helical bundle 
with one UMC molecule per helix. Main-chain and side-chain density could not be 
interpreted for some terminal residues (residues 1-3 of chain A; 1-4, 51-52 of chain B; 1-
2, 47-52 of chain C; and 1-4, 51-52 of chain D). The asymmetric unit also contains two 
cadmium atoms, one acetate molecule and ten dioxane molecules. The cadmium atoms 
are each coordinated by four carboxylate anions: one cadmium is coordinated by four 
glutamate side chains (Figure 3), and the other cadmium is coordinated by three 
glutamate side chains and an acetate molecule. 
 Several dioxane molecules mediate helix-helix packing (Figure 4). This 
observation led us to examine the effect of dioxane on the helicity and oligomerization of 
UMC in solution.   
 Helicity was examined by far-UV circular dichroism. Ellipticity was virtually 
unchanged when UMC was exposed to CdCl2 alone (not shown) or CdCl2 with 10% 
dioxane (Figure 5). However, exposure of UMC to 20% dioxane lowered the minima at 
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208 and 222 nm and was thus indicative of an increase in helicity. The increase, while 
significant, was still less than that for 30% trifluoroethanol (TFE), a helix stabilizer.9 
Higher percentages of dioxane did not further increase the helicity significantly (not 
shown). 
 
Table 1. X-ray data collection and refinement statistics 
 
 R-Axis IV  SSRLa   
Unit cell 
  a 50.767 Å  50.712 Å 
  b 52.562 Å  52.646 Å 
  c 82.147 Å  82.182 Å 
Space group P212121  P212121 
Wavelength 1.5418 Å  0.8265 Å 
Resolution range 81.65 – 1.90 Å 44.32 – 1.65 Å 
No. of reflections collected 208991  204302 
No. of unique reflections 17953  27060 
Rmerge
b 5.6% (55.1%)c 4.7% (19.6%) 
I/(I)  10.1 (1.3)  31.8 (8.5) 
Completeness 99.9% (99.5%) 99.8% (100.0%) 
 
Final refinement 
  Rcryst   18.7% 
  Rfree
d   22.7% 
  Figure of merit   0.863 
  No. of residues   368 
  No. of water molecules   168 
  No. of non protein molecules   11 
  Mean B value   28.1 Å2 
 
RMSD from standard stereochemistry 
  Bond length   0.017 Å 
  Bond angle   1.527° 
 
Ramachandran plot statistics 
  Most favored regions   99.4% 
  Additional allowed regions   0.6% 
  Generously allowed regions   0.0% 
  Disallowed regions   0.0% 
 
a Stanford Synchrotron Radiation Laboratory. 
b Rmerge =  I  <I> /  (I), where I is the observed intensity and <I> is the average intensity. 
c Numbers in parentheses represent values in the highest resolution shell (1.90-1.99 Å for the R–Axis IV 
data and 1.652-1.695 Å for the SSRL data). 
d Rfree was calculated for 5% of randomly selected reflections excluded from refinement. 
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Figure 3. Coordination of one of the two cadmium atoms by four glutamates. The 
coloring is cyan (chain A), green (chain B), yellow (chain C), purple (cadmium), and red 
(oxygen). The A-weighted density map is contoured at 2, up to 3.5 Å from the 
cadmium. Chain C is from a symmetry-related molecule. 
 
 
Figure 4. Dioxane molecules mediating helix-helix packing. The coloring is green (chain 
B), brown (chain C), yellow (dioxane), red (oxygen), and blue (nitrogen). The A-
weighted density map is contoured at 1, up to 3 Å from the dioxane. 
 
 
 Oligomerization was examined by sedimentation velocity analytical 
ultracentrifugation. Exposure to 20% dioxane significantly decreased the percentage of 
monomeric UMC, from 81.4% to 62.8%, and concomitantly increased the percentage of 
dimeric UMC, from 14.8% to 36.3% (Figure 6). The frictional ratio, which describes the 
shape of the sedimenting species, also increased. A sphere has a ratio of ~1.2, whereas 
rodlike shapes have higher ratios. The frictional ratio increased from 1.22 to 1.42 in the 
presence of dioxane. 
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Figure 5. Far-UV circular dichroism analysis of UMC. The spectra are UMC (); UMC 
in 5 mM CdCl2 and 10% dioxane (triangles); UMC in 20% dioxane (+); and UMC in 
30% TFE (circles). 
 
 
Figure 6. Molar mass distribution of UMC as determined by sedimentation velocity: 
UMC (solid line); UMC in 20% dioxane (dotted line). 
 
Discussion 
 Our crystal structure of UMC is quite dissimilar to the target homeodomain fold. 
Instead of three short helices, each monomer is a single long helix. However, the 
crystallization conditions, especially the high concentration of dioxane, may induce UMC 
into a conformation unrepresentative of UMC in solution.  
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Increased helicity and oligomerization due to dioxane 
Dioxane increased the helicity of UMC. While dioxane had a significant effect, the 
[]222 for 20% dioxane (25,000 deg cm2 / dmol res) was less negative than for 30% 
TFE (31,000 deg cm2 / dmol res).  
 The effect of dioxane on increasing helicity has been reported previously10-12. The 
increase in helicity can be explained entropically: non-polar solvent increases the 
entropic cost of forming protein hydrogen bonds to water and thus decreases the relative 
cost of forming helical hydrogen bonds. The use of organic solvents may have played a 
role in the crystallization of a number of short aminoisobutyric acid-containing peptides, 
which also adopt extended continuous helical structures.13 
 The sedimentation velocity data showed that dioxane increases the 
oligomerization state and frictional ratio of UMC. While there was a significant increase 
in the amount of dimer, there was no evidence of a tetramer, as might be expected from 
the crystal structure. One explanation is that formation of a tetrameric species requires 
cadmium. Although CdCl2 alone and CdCl2 with 10% dioxane had no effect on the 
helicity of UMC, low millimolar amounts of CdCl2 (e.g., 2–5 mM) caused essentially all 
UMC to precipitate out in the presence of > 15% dioxane. The UMC crystals appeared a 
couple of weeks after precipitate had formed in the well. Perhaps cadmium further 
increases the dioxane-induced helicity and/or oligomerization of UMC but requires the 
very slow mixing that occurs in the crystallization well.  
   
Conclusion 
Overall, the crystal structure has increased helicity and altered oligomerization compared 
to the target fold. Both of these differences were inducible by dioxane. We thus attribute 
at least part of the discrepancy between the target fold and the crystal structure of the 
designed sequence to the presence of a high concentration of dioxane. Although low 
concentrations (1%-2%) of dioxane have been reported to improve crystallization of 
some proteins,14,15 we suggest that high concentrations of dioxane be used with caution.  
 
 
   89 
   
Materials and methods 
Protein design and purification 
 The UMC design, construction, expression, and purification were similar to our 
previous engrailed designs1,2 and are described in detail elsewhere.4 A brief summary is 
below. 
 The starting model for all engrailed designs was PDB entry 1enh.3 Because 
residue 35 has a positive phi angle it was preserved as glycine. The UMC design protocol 
was identical to the B6 design protocol of Marshall and Mayo,1 except that in the UMC 
design all residues were designed simultaneously, and a Monte Carlo simulation5 was 
used instead of a dead-end elimination based algorithm16 to find a low-energy sequence. 
The protein was expressed in E. coli and purified via freeze-thaw17 followed by HPLC 
using an acetonitrile/water gradient containing 0.1% TFA. Mass spectrometry indicated 
UMC has an N-terminal methionine. 
 
Crystallization 
 Crystals were obtained using a modified sitting drop method that utilizes a 
“reservoir mimic.” The well reservoir is minimized to contain only the volatile reagents 
and NaCl. The nonvolatile reagents normally in the reservoir are kept in a separate 
solution (the mimic) that is only added to the crystallization drop. 
 We also used Fluorinert (Hampton Research), which is expected to be denser than 
the drop and allow the drop to float. Under our conditions, Fluorinert floated above the 
drop. However, this serendipitously slowed the otherwise rapid crystal degradation that 
would happen upon well opening and presumably due to the volatility of dioxane.  
 The initial crystallization condition was 35% dioxane (Hampton Research Crystal 
Screen 2). The final crystallization conditions were as follows: the well reservoir 
contained 500 μL of either 24 or 25% dioxane; the well post contained 1 μL of protein 
solution (~17 mg/mL UMC, 50 μM sodium citrate at pH 5.5) followed by 1 μL of 
reservoir mimic solution (0.1 M MES at pH 5.7, 30% PEG 400, 10–15 mM CdCl2); 20 
μL of Fluorinert (Hampton Research) was then added on top of each post. Trays were 
incubated at 20° C; crystals appeared after about two weeks. The largest crystals had 
dimensions of approximately 150  150  200 μm.  
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Structure determination 
Data were collected using a Cu source on a Rigaku RU3HR generator with an R–AXIS 
IV detector at 100 K. Data were processed using the HKL program suite v1.97.9.18 Initial 
electron density maps were generated using SAD phasing as implemented in the program 
suite Elves.19 The final model was determined by subsequent rounds of building and 
refinement using O20 and REFMAC21 from the CCP4 program suite22 to an R–factor of 
22.2% (Rfree = 27.8%). Final refinement was done with high-resolution data collected at 
beamline 9.2 at the Stanford Synchrotron Radiation Laboratory and produced a final R–
factor of 18.7% (Rfree = 22.7%).  
 Coordinates and structure factors have been deposited in the PDB under the 
accession code 1Y66.  
  
Circular dichroism and sedimentation velocity 
Circular dichroism data were collected on an Aviv 62DS spectrometer equipped with a 
thermoelectric unit. Wavelength scans were done from 190-250 nm at 20° C in a 0.1 mm 
path-length cell. All samples contained 532 μM UMC and 10 mM sodium citrate, pH 5.5. 
Protein concentration was determined by absorbance at 280 nm in the presence of 8 M 
guanidine HCl.  
 Sedimentation velocity data were collected on a Beckman XL-I analytical 
ultracentrifuge with interference optics. Samples contained 532 μM UMC and 0.1 M 
sodium citrate, pH 5.5. Samples were dialyzed for 3 h at room temperature against ~100 
mL of the corresponding solution without protein. A 12 mm Epon centerpiece and 
sapphire windows were used. The rotor, an An-60 Ti, was spun at 55,000 RPM at 25° C. 
Scans were taken every 5 min for ~15 h. Data were analyzed with SEDFIT.23 
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